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ABSTRACT 
 
 
SURVIVAL SIGNALS INDUCED BY CHOLESTEROL OXIDATION BY-
PRODUCTS IN ATHEROSCLEROSIS 
 
 
Beyza Vurusaner Aktas  
Biological Sciences and Bioengineering, Ph.D. Thesis, 2015  
Thesis Supervisor: Huveyda Basaga 
 
Keywords: Oxysterols, 27-Hydroxycholesterol, Survival signaling, ROS, Nrf2 
 
Atherosclerosis is the most prevalent cause of morbidity and mortality developed 
countries. Oxysterols are a family of 27-carbon molecules originated from cholesterol 
oxidation and the atherogenic potential of oxysterols is linked to their ability to induce 
apoptosis, vascular smooth muscle cell proliferation and monocyte migration. 
Apparently, these compounds are able to modulate not only pro-apoptotic but also anti-
apoptotic signals in targeted cells; however, their anti-apoptotic effect has not been 
investigated in depth. Hence, we aimed to elucidate the molecular mechanisms 
underlying the survival signaling elicited by 27-hydroxycholesterol (27-OH) which is 
the most represented oxysterol in human blood. Using human promonocytic cells 
(U937) challenged with a relatively low (10 M) concentration of 27-OH, a marked 
while transient increase of intracellular ROS level that enhanced both MEK-ERK and 
PI3K-Akt phosphorylation was observed between 6 and 24 hours, paralleled by Bad 
phosphorylation, resulting to be a crucial event in delaying apoptotic death.  In turn, the 
knock down of ERK and Akt by means of selective inhibitors, increased ROS 
production at 12 h showing that ERK/Akt axis was responsible of a sustained quenching 
of ROS production. Involvement of antioxidant Nrf2 and its target genes, HO-1 and 
NQO-1 in this early survival response were shown. It thus appears that Nrf2 is 
responsible for the quenching of the oxidative imbalance exerted in 27-OH challenged 
cells that analyzed by confocal microscopy. The data obtained highlight oxysterols’ 
ability to promote cell survival that might contribute to the pathogenesis of 
inflammation-driven chronic diseases such as atherosclerosis. 
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ÖZET 
 
 
KOLESTEROL OKSĠDASYON ÜRÜNLERĠNĠN ATEROSKLEROZDA 
ĠNDÜKLEDĠĞĠ SAĞKALIM SĠNYALLERĠ 
 
 
Beyza Vurusaner Aktas  
Biological Sciences and Bioengineering, Ph.D. Thesis, 2015  
Thesis Supervisor: Huveyda Basaga 
 
Anahtar kelimeler: Oksisteroller, 27-Hidroksikolesterol, Sağkalım sinyalleri, ROS, Nrf2 
 
Dünyada ve özellikle geliĢmiĢ ülkelerde damar sertliği (ateroskleroz) ölüm ve sakat 
kalmanın en yaygın sebebidir. 27-karbon ihtiva eden oksisteroller, kolesterolün oksidize 
türevleridir ve oksisterollerin aterojenik potansiyelleri; tetikledikleri apoptoz, vasküler 
düz kas hücre proliferasyonu ve monosit göçü ile ilgilidir. Elde edilen ön bulgulara 
göre, oksisteroller apoptotik sinyallerin yanında aynı zamanda anti-apoptotik sinyalleri 
de düzenlerler; ancak konuyla ilgili yeterince detaylı araĢtırma bulunmamaktadır. Bu 
nedenle, araĢtırmamızda, insan kanında en çok rastlanan oksisterol olan 27-
hidroksikolesterol (27-OH), tarafından tetiklenen sağkalım mekanizmasının moleküler 
seviyede açıklanması hedeflenmiĢtir. DüĢük dozda (10 M) 27-OH uygulanan U937 
monosit hücrelerinde , konfokal mikroskopu ile hücreiçi ROS seviyesinde gözlenen 
hızlı ancak geçici yükselme hem MEK-ERK hem de PI3K-Akt fosforilasyonunu 6. ve 
24. saatler arasında artırmıĢtır, buna paralel olarak apoptotik ölümü ertelemede önemli 
rolü olan Bad fosforilasyonu tespit edilmiĢtir. Buna karĢılık, Erk ve Akt ye özgü 
susturucuların uygulanması ROS üretiminin artıĢına neden olmuĢ ve ERK/Akt 
ekseninin süregelen ROS üretiminin baskılanmasından sorumlu olduğunu göstermiĢtir. 
Antioksidan Nrf2 defansının ve hedef genleri olan HO-1 ve NQO-1 nin bahsi geçen 
erken saatlerdeki sağkalım sinyalinde yeraldığı gösterilmiĢtir. Elde edilen bulgularda, 
Nrf2 nin konfokal mikroskopu ile analiz edilen 27-OH tarafından indüklenen oksidatif 
dengesizliği gidermekle sorumlu olduğu gösterilmiĢtir. Elde edilen sonuçlar, 
oksisterollerin düĢük dozda hücre sağkalımını desteklemekte olduğunu ve ateroskleroz 
gibi enflamasyon güdümlü kronik hastalıkların patojenezine etki ettiğini 
vurgulamaktadır. 
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1. INTRODUCTION 
 
 
 
1.1 Oxysterols 
 
1.1.1 Chemical structures and origins of oxysterols 
 
Cholesterol is undoubtedly a molecule of key biological importance, being the 
structural core of estrogens and androgens, starting the synthesis of vitamin D and 
biliary acids and playing a primary role in stabilization and function of membrane lipid 
rafts, but its popularity” is biased by the fact that hypercholesterolemia actually 
represents a main risk factor of cardiovascular disease, neurodegeneration, 
inflammatory bowel disease and cancer. 
 
Going a bit deeper in evaluating the pathophysiological impact of cholesterol, it 
appears clear that this powerful molecule exert a number of effects not simply per se but 
for a significant percentage through the biochemical properties exerted by its 
metabolites. Among the latter ones, an increasing attention is drawn by the family of 
cholesterol oxidation products termed oxysterols, 27-carbon molecules that, with 
respect to cholesterol, show an epoxide or ketone or an additional hydroxyl group in the 
sterol nucleus and/or a hydroxyl group in the side chain. Within this family of 
compounds there are components that are from 10 to 100 more chemically reactive than 
unoxidized cholesterol, thus suggesting their involvement in many of the biochemical 
and biological effects ascribed to cholesterol (Leonarduzzi et al., 2002; Schroepfer, 
2000).  
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In oxysterols physico-chemical features studies, it has been clearly established 
that they contain a second oxygen atom as a carbonyl, hydroxyl or epoxide group and fit 
perfectly into the lipid bilayer of biological membranes. In Figure 1.1., chemical 
structures of principal oxysterols of biological interest are reported. Various oxysterols 
have been found in appreciable quantities in human tissues and biological fluids, 
including human plasma. Due to their elevated levels have been elected in foam cells 
and atherogenic lipoproteins it is suggested that oxysterols play active role in 
atherosclerotic plaque formation (Carpenter et al., 1995; Hodis et al., 1991). Moreover, 
oxidized cholesterol derivatives have been shown to have higher atherogenic potential 
than native cholesterol (Kumar and Singhal, 1991). 
 
 
Figure 1.1. Chemical structures of some oxysterols. (Leonarduzzi et al., 2002) 
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The presence of oxysterols in human plasma can be explained in several 
different ways; from an exogenous source by absorption of dietary oxysterols or from 
endogenous sources that oxysterols formed by enzymatic or non-enzymatic oxidation 
(Otaegui-Arrazola et al., 2010). Dietary sources of oxysterols are cholesterol rich food 
products including eggs, milk powders, dairy products cheese, red meat, brain, liver, 
kidney, ham and stored fish (Leonarduzzi et al., 2002; Lordan et al., 2009). Among the 
oxysterols 25-hydroxycholesterol, 7-ketocholesterol, 7β-hydroxycholesterol and 5β, 6β-
epoxycholesterol is the most commonly detected ones in processed food (van Reyk et 
al., 2006). In Table 1.1., both non enzymatic and enzymatic origin of the most 
representative oxysterols are reported.  
 
Endogenous formation of oxysterols through the non-enzymatic oxidation of 
cholesterol mainly affects the sterol ring and in general mediated by radical 
mechanisms. On the other hand, enzymatic oxidation reacts in the side-chain of sterol 
structures. Some of the most abundant oxysterols such as 24-, 25- and 27-HCs found in 
vivo, are generated by enzymatic side-chain hydroxylation of cholesterol (Russell, 
2000). Two key enzymes involved in cholesterol conversion to bile acids are sterol 27-
hydroxylase (CYP27A1) and cholesterol 24-hydroxylase (CYP46A1) that are P450 
enzymes and catalyze the hydroxylation reactions to form 27- and 24-HCs (Björkhem et 
al., 1994; Bretillon et al., 2007). The enzyme sterol 27-hydroxylase is a mitochondrial 
oxidase that is expressed in various tissues and cells, commonly in liver and 
macrophages (Brown et al., 2000; Russell, 2000). The oxysterol 27-hydroxycholesterol 
(27-OH) is one of the most common oxysterols in the peripheral blood of healthy 
volunteers as well as in atherosclerotic lesions (Honda et al., 2009; Riendeau and 
Garenc, 2009). Recently, this oxysterol has been reported as a selective estrogen 
receptor modulator (Umetani et al., 2007) and also a very good ligand of liver X 
receptors (LXRs) (Janowski et al., 1999, 1996), nuclear receptors that function as 
master transcription factors, in cell metabolism, macrophage survival, inflammation, 
and immunity (Bensinger and Tontonoz, 2008). 
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Table 1.1. Origin of oxysterols  
 
It is well accepted that lipid oxidation products including oxysterols are able to 
modulate many biological activities, thus the biochemical effects of oxysterols are 
varied from modulation of lipid homeostasis as well as induction of cell death, fibrosis 
and chronic inflammation (Leonarduzzi et al., 2007).  
 
Nowadays, new emphasis to the beneficial effects exerted by at least defined 
oxysterols, has been given by the vaste reconsideration that side-chain cholesterol 
oxides like 24-, 25- and 27-hydroxycholesterol (24-OH, 25-OH and 27-OH) are among 
the best ligands of a variety of physiologically important nuclear receptors (PPARs, 
LXRs) and by this way could modulate not only the inflammatory and immunological 
response but also cell viability, metabolism and function (Bensinger and Tontonoz, 
2008; Janowski et al., 1999, 1996). 
 
While the sterol ring-derived oxysterol, namely 7k-cholesterol (also named 7-
oxo-cholesterol), definitely not binding to LXRs, would induce and sustain mainly pro-
inflammatory reactions in human monocyte-derived macrophages (Buttari et al., 2013), 
27-OH, good LXR ligand, should rather polarize human macrophages towards an anti-
Exogenous source
DIET:
Already present in foods 
(meat, milk, egg)
DIET:
Formed by autoxidation 
of foodstuff
Endogenous source
ENZYMATIC PATHWAYS:
27-Hydroxylase
7α-Hydroxylase
7-Ketone dehydrogenase
5α,6α-Epoxidase
NON-ENZYMATIC 
PATHWAYS:
Attack by ROS
Attack by peroxyl and alkoxyl 
radicals
Leukocyte/H2O2/HOCl system
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inflammatory state. In any case, it becomes evident that various oxysterols are able to 
trigger and promote signal transduction pathways, which can be either dependent or 
independent from the binding to nuclear receptors.   
 
Before trying to straighten out the actual knowledge about oxysterols and signal 
transduction, it is noteworthy to mention that 25-OH and 27-OH have been shown to 
exert a broad antiviral effect against a large number of viruses with or without lipid 
envelope, a highly promising beneficial property that is definitely mediated by a 
complex intracellular signaling, yet to be properly elucidated. 
 
1.1.2 Oxysterols and signal transduction 
 
There is not a unique way by which oxysterols can trigger cell signaling within 
cells and, as a consequence, the signaling pathways they can activate are quite a 
number. Definitely, uptake and cellular trafficking appear to significantly differ 
between sterol ring oxysterols and side chain oxysterols, even if the mechanisms 
underlying such events are far from being fully elucidated. 
 
Because of their relative lower hydrophobic and higher amphipathic properties 
as to cholesterol, oxysterols diffuse much better through the lipid bilayer of 
biomembranes and the diffusion rate is concentration dependent, but, as in the case of 
cholesterol, a certain percent of both exogenous and endogenous oxysterols resides in 
the plasma membrane (PM), mainly localized in lipids rafts, i.e. small (10–200 nm) 
heterogeneous PM microdomains rich in cholesterol, sphingomyelin and 
phosphatidylcholine.  
 
Of note, from 60 to 80% of total cell cholesterol is contained in the PM (Liscum 
and Munn, 1999) and lipid raft phosphatidylcholines are Phosphatidyl Inositol 4,5 
Trisphosphate (PIP2) and Phosphatidyl Inositol 3,4,5 Trisphosphate (PIP3) (Wang and 
Richards, 2012), namely two key regulator of several signaling pathways, including the 
PIP3-Akt survival signaling cascade (Di Paolo and De Camilli, 2006). The effect of 
oxysterols on lipid rafts formation and stability is not homogeneous. While 27-OH and 
25-OH seem to also favor raft physiological functions, 7-ketocholesterol (7K) and 7β-
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hydroxycholesterol (7βOH) act rather as inhibitors and activate cytotoxic signals  
(Massey, 2006; Ragot et al., 2013). Up-regulation of  the phospholipase c/PIP2 
signaling cascade was proved to be exerted by a diet-compatible mixture of oxysterols, 
eventually leading to scavenger receptor CD36 overexpression in U937 promonocytic 
cells, and involving the PKC/MEK/ERK pathway (Leonarduzzi et al., 2010). 
 
Another primary trigger of the PKC/MEK/ERK pathway, located as well as 
phospholipase c/PIP2 in caveolae and lipid rafts is represented by NADPH oxidase 
(NOX) (Jin et al., 2011), whose assembly and activation within plasma membrane has 
been investigated in details in phagocytic cells, but nowadays recognized to be present 
in various isoforms in most cell types. The NOX family of NADPH oxidases certainly 
is a predominant source or reactive oxygen species (ROS) under physiological 
conditions and oxysterols were shown able to upregulate at least some members of this 
family of enzymes, in particular NOX1 in colonic cells (Biasi et al., 2013) and neuronal 
cells (Gamba et al., 2011) and NOX2 in cells of the macrophage lineage (Leonarduzzi 
et al., 2004; Vurusaner et al., 2014). Oxysterol-mediated ROS signaling through 
PKC/MEK/ERK pathway was demonstrated to sustain the pro-inflammatory effects 
(Biasi et al., 2009) as well as CD36 induction (Leonarduzzi et al., 2010), but also the 
pro-survival stimuli exerted by oxysterols (Vurusaner et al., 2014). 
 
Still on plasma membrane, at least defined oxysterols of pathophysiological 
relevance, like 25-OH and 27-OH, could activate the Hedgehog cell signaling (de 
Weille et al., 2013; Nedelcu et al., 2013), a transduction pathway based on two PM 
proteins, namely the receptor Patched (Ptc) and the transducer Smoothened (Smo), 
involved in the regulation of a number of cellular processes besides embryogenesis 
(Cohen, 2010). Apparently, oxysterols physically interact with Smo (Nedelcu et al., 
2013) and the perturbation of this process is considered to play a significant role in 
carcinogenesis (de Weille et al., 2013). Smo function and Hedgehog signaling were 
shown as being strictly dependent on lipid raft integrity and function (Shi et al., 2013). 
Moreover, the internalization of oxidized low density lipoproteins (LDL) occurs at the 
level of lipid rafts and represents a further way of oxysterols’ uptake by the cells. The 
latter process mainly depends on CD36 and related scavenger receptors (Kiyanagi et al., 
2011; Rios et al., 2013), even if a receptor-independent entry of oxysterols within 
macrophagic cells was described as promoted by lipoprotein lipase (Makoveichuk et al., 
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2004). In this relation, important appears that mentioned ability of a biologically 
relevant mixture of oxysterols to upregulate expression and synthesis of CD36 
(Leonarduzzi et al., 2010, 2008). 
 
The cell incorporation of lipoproteins containing also oxysterols leads to 
conclude that at least one way by which these molecules, besides the localization within 
lipid rafts, may move intracellularly is vesicular. But there is also a non vesicular way 
of oxysterols’ transport within different cell compartments (Maxfield and Wüstner, 
2002), possibly not only but certainly involving OSBPs. Oxysterol-binding proteins 
(OSBPs) are a group of cytoplasmic carrier proteins having oxysterols as major ligands 
that are involved in lipid homeostasis and sterol-dependent signal transduction 
(Olkkonen et al., 2012). With regard to the latter point and, in particular, the hereafter 
considered oxysterol-triggered survival signaling, OSBPs was displaying a key role in 
the modulation of ERK1/2 phosphorylation level, by forming an active oligomer with 
the serine/threonine phosphatase PP2A (Wang et al., 2005). OSPBs appear to play a 
major role in oxysterol-modulated signal transduction since allow at least part of the 
non vesicular transport of these cholesterol derivatives from the plasma membrane to 
intracellular organelles. 
 
A further statement, even if the overall picture is far from being elucidated in 
full, is that vesicular and not vesicular transport of cholesterol and oxysterols, combined 
with their biomembrane crossing down a free-energy gradient or for passive diffusion, 
do operate the complex intracellular movements of these important molecules. 
 
1.1.3 Oxysterol-mediated activation of transcription factors 
 
Cell signaling induced and sustained by oxysterols of pathophysiological interest 
is combined with the activation of a number of transcription factors, that actually appear 
to be redox modulated and include sterol regulatory element binding proteins 
(SREBPs), nuclear factor kappa B (NF-kB), Toll Like Receptors (TLRs), nuclear factor 
erythroid 2-related factor 2 (Nrf2), Liver X Receptors (LXRs), RXR (Retinoid X 
Receptor), Peroxisome Proliferator-Activated Receptors (PPARs), Retinoic Acid 
Receptor-Related Orphan Receptors (RORs), estrogen receptors (ERs). 
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SREBPs are localized in a precursor form within the endoplasmic reticulum, complexed 
with SREBP cleavage activating protein (SCAP) that regulates its transport into the 
Golgi and consequent activation. Once activated, SREBPs translocate in the nucleus 
where bind to the sterol responsive elements of the genes involved in fatty acids and 
cholesterol synthesis and uptake (Yan and Olkkonen, 2008). Mainly side-chain 
oxysterols are good ligands and/or activators of SREBPs (Björkhem, 2009). 
 
The widely recognized pro-inflammatory effect exhibited by a variety of 
oxysterols is definitely based, at least in part, on the strong activation and nuclear 
translocation of NF-kB, through the ERK-JNK pathway (Leonarduzzi et al., 2005; 
Umetani et al., 2014), with or without the involvement of estrogen receptor α (Erα) 
(Umetani et al., 2014). There is a strong experimental evidence that a variety of 
cholesterol oxidation products may upregulate a large number of inflammation-related 
genes whose expression is NF-kB-dependent, like those coding for interleukin-1β (IL-
1β) and interleukin-6 (IL-6), interleukin-8 (IL-8) and monocyte chemotactic protein-1 
(MCP-1), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion 
molecule-1 (VCAM-1) (Poli et al., 2013). 
 
Moreover, enhanced NF-kB nuclear translocation and consequent gene 
transcription stem from the activation of Toll-like receptors (TLRs), a family of 
receptors primarily involved in the innate immunity and localized on the plasma 
membrane and/or in endosomes, that may also be induced by oxysterols such as 27-OH 
and 25-OH (Gargiulo et al., 2015). 
 
Another redox-sensitive transcription factor that like NF-kB is kept in an 
inactive form within the cytoplasm but, once activated, translocates into the nucleus, 
namely Nrf2, has recently been considered a possible target of oxysterol-mediated cell 
signaling, as reported in more details in section 1.4.3.1. 
 
A number of nuclear receptors playing a key role in a variety of physiological 
processes recognize oxysterols as primary ligands. This is especially the case of LXRα 
and β that form obligate heterodimers with RXR and then act as sensors of cholesterol 
and its oxidative metabolites, mainly side-chain oxysterols (Janowski et al., 1999, 
1996). The two oxysterols mainly investigated for their LXR binding property are 24-
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OH and 27-OH and their involvement in the physiological regulation of cholesterol and 
lipid metabolism strongly proposed (Björkhem, 2013, 2009). An additional interesting 
effect that has been ascribed to side-chain-oxysterols and triggered through the LXR-
RXR pathway, is the stimulation of an anti-inflammatory phenotype in macrophages, 
i.e. an important process in the modulation of inflammatory and immunologic events 
(Töröcsik et al., 2009), which can lead to the survival of immune cells (Joseph et al., 
2004) but also of foam cells (Sallam et al., 2014)  and tumor cells (York and Bensinger, 
2013). Still, the overall effect of oxysterols, usually present in mixture within human 
tissues and biological fluids, on the modulation of inflammation and immunity is far 
from being fully elucidated. Confirming the complexity of the subject is the report of a 
pro-inflammatory effect of the sterol ring oxysterol 7K on both human type I and type 2 
differentiated macrophages.  
 
Not only LXRs but also the PPARα, β/δ and γ form heterodimers with RXR, an 
example of integrated modulation of cell metabolism and inflammatory reactions (Hong 
and Tontonoz, 2008). There is not much evidence of an involvement of PPARs in signal 
transduction operated by oxysterols, but the very likely interconnection between the 
various nuclear receptor classes suggests not to exclude a priori while deeper investigate 
the possible modulation of the different PPAR isoforms by cholesterol oxides. At 
present, one study is available which proved the involvement of PPARγ isoform in the 
up-regulation of CD36 scavenger receptor in U937 promonocytic cells challenged with 
a biologically relevant mixture of oxysterols (Leonarduzzi et al., 2008). 
 
A further class of nuclear receptor, namely RORα, β, γ, playing an important 
role in both development and functions of immune system, brain, retina and various 
other tissues (Burris et al., 2012) recognize several oxysterols as ligands. In this 
relation, the few data so far available indicate a significant inhibitory regulation  of 
RORs as exerted by 7α-OH, 7β-OH, 7K (Wang et al., 2010b) and, with regard to side 
chain cholesterol oxides, by 24-OH (Wang et al., 2010a). 
 
Finally and importantly, 27-OH was definitely demonstrated to act as competitive 
ligand for Erα and ERβ, by this way triggering intracellular signals potentially able to 
modulate cancer cell growth and atherosclerosis progression (Lee et al., 2014; Umetani 
et al., 2014, 2007). Consistently, a marked promotion of cell proliferation was observed 
10 
 
in human breast and ovarian cell lines, as well as in murine cardiomyocytes following 
treatment with 25-OH, which was shown to signal trough Erα (Lappano et al., 2011). 
Again, as in the case of oxysterol-mediated modulation of the activity of other nuclear 
receptors, because of the complex and yet largely unknown interaction between them, it 
is better not to draw any conclusion, for instance claiming that defined oxysterols can 
simply favor cancer proliferation and growth. In this regard, there is a line of evidence 
indicating that oxysterols could on the contrary counteract cancer progression, for 
instance in the case of tamoxifen and related drugs, by stimulating malignant cell 
differentiation and apoptotic (de Medina et al., 2011). 
 
 
1.2 Programmed Cell Death 
 
Programmed cell death occurs during embryonic development, preservation of 
tissue homeostasis, immune system regulation and morphogenesis throughout 
organism’s life. Programmed cell death can be divided into three main types including 
apoptosis, necrosis and autophagy. Many reliable in vitro studies demonstrated the 
potential pro-apoptotic effect of oxysterols; thus we will especially focus on apoptotic 
cell death throughout this thesis. 
 
1.2.1 Apoptosis  
 
Apoptosis is one of the major types of programmed cell death which is 
genetically controlled and carried out in an ordered process in response to a wide range 
of exogenous and endogenous stimuli. Apoptosis is characterized by distinct 
morphological features including cell shrinkage, membrane blebbing, nuclear 
fragmentation, chromatin condensation and consequent phagocytosis by macrophages to 
for the deletion of damaged cells (Strasser et al., 2000). 
 
Apoptosis can be divided into different stages including initiation, execution and 
removal of apoptotic bodies. There are two major pathways that trigger apoptosis: the 
death receptor-dependent (extrinsic) pathway or the mitochondrial (intrinsic pathway) 
(Fig. 1.2.). The extrinsic pathway can be initiated by external signals such as death 
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activators which bind to surface receptors. Binding of specific ligands like Fas ligand 
(FasL) or TNF-a to the death receptors on the target cells induces receptor 
multimerization leading to death inducing signaling complex (DISC) formation 
(Ashkenazi and Dixit, 1998). An adaptor protein, Fas associated death domain protein 
(FADD) acts as a bridge between DISC and caspase- 8, which is crucial for recruitment 
of caspase-8 to DISC, and also for activation of caspase-8 that results in caspase-3 
activation to initiate degradation of the cell (Bodmer et al., 2000; Sprick et al., 2000). 
 
 
Figure 1.2. Extrinsic and intrinsic pathways of apoptosis. (Kutuk and Basaga, 2006) 
 
 
The intrinsic pathway of apoptosis is centered on the mitochondrial outer 
membrane permeabilization (MMP) and initiated by DNA damaging agents, heat, 
radiation, hypoxia and infection (Moissac et al., 2000).  Bcl-2 family members are the 
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main apoptotic sensors in intrinsic pathway that regulate the survival or death signals in 
the mitochondria. In response to apoptotic stimuli, MMP can be induced by pro-
apoptotic members of Bcl-2 family proteins that lead to the release of small pro-
apoptotic including cytochrome c, second mitochondrial activator of caspases/direct 
IAP-binding protein of low isoelectric point -pI (Smac/DIABLO), endonuclease G 
(Endo G) and apoptosis inducing factor (AIF) (Adrain et al., 2001). Once cytrochrome c 
released into the cytosol, it interacts with apoptotic protease-activating factor-1 (Apaf-1) 
and ATP/dATP. As a consequent of the complex formation, pro-caspase-9 is recruited 
to form apoptosome, which in turn cleaves and activates caspase-3, the effector protein 
that initiates degradation of nuclear material and proteases (van Gurp et al., 2003). 
Effector caspases including caspase-3, -6 and -7 cleaves various substrates such as poly 
(ADP-ribose) polymerase (PARP) that leads to the morphological and biochemical 
changes seen in apoptotic cells. In addition to cytochrome c release, Smac/DIABLO 
may promote caspase activation through competing with caspase-9 to bind to inhibitor 
of apoptosis proteins (IAPs) that result in apoptosis by eliminating IAP inhibition of 
caspases (Adrain et al., 2001). 
 
In the early stages of mitochondrial pathway of apoptosis, regulation of 
intracellular Ca
2+
 stores appears central. In response to apoptotic stimuli, Ca
2+
 mobilizes 
from endoplasmic reticulum (ER) stores to the mitochondria. Then, the mitochondrial 
calcium uptake induces rupture of the subcellular organelle and modulate calcium-
dependent enzymes that crosstalk with other apoptotic mechanisms. Moreover, the anti-
apoptotic proteins of Bcl-2 family members which are also localized in the ER, have 
active role for Ca
2 +
 homeostasis in apoptosis (Oakes et al., 2003). 
. 
1.2.1.1 Bcl-2 family  
 
Bcl-2 (B-cell lymphoma 2) family members are crucial regulators of intrinsic 
pathway of apoptosis. The balance between pro-apoptotic Bcl-2 family proteins such as 
Bad, Bax, Bim, Bok, Bcl-xs and anti-apoptotic proteins such as Bcl-2, Bcl-xl, Mcl-1 
determine if a cell undergoes apoptosis. These family members share at least one of the 
four Bcl-2 homology domains; BH1, BH2, BH3, BH4 and based on the functional and 
structural properties, they can be classified into three groups (Cory and Adams, 2002; 
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Kutuk and Basaga, 2006) (Fig. 1.3.). Group I includes multidomain anti-apoptotic 
members (Bcl-2/Bcl-XL/Bcl-w/Mcl-1/A1/Bfl 1) that inhibit apoptosis by binding to and 
sequestering pro-apoptotic Bcl-2 family members. Proteins belongs to Group II involves 
Bax and Bak, multidomain pro-apoptotic members that acting as promoters of cell 
death, through inducing cytochrome c release from the mitochondria (Mikhailov et al., 
2003). Group III pro-apoptotic proteins share only BH3 domain (Bid/Bad/Bik/Bim) that 
in response to apoptotic stimuli, they translocate from the cytosol to the mitochondria to 
inhibit Bcl-2/xl and activate Bax or Bak to induce the release of apoptotic proteins 
(Kutuk and Basaga, 2006). The function of BH3 domain only proteins can be 
characterized by two main pathways. In the first pathway, direct activators (Bim, Bid 
and Puma) interact with pro-apoptotic Bax and Bak to induce their activation while anti-
apoptotic proteins may form complexes to inhibit this activation.  The other pathway 
involves sensitizers, other BH3 only members (Bad) bind to anti-apoptotic Bcl-2 
members and prevent them interacting and sequestering Bid and Bim, which can lead to 
dissociation of Bax and Bak to be active (Kim et al., 2006). 
 
 
 
Figure 1.3. Bcl-2 protein family members. (Adapted from (Tezil and Basaga, 2013)) 
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Under normal conditions, anti-apoptotic Bcl-2 and Bcl-xl are expressed in the 
outer membrane of the mitochondria that prevent the opening of mitochondrial 
permeability transition pore (Leonarduzzi et al., 2007). In the activation stages of the 
mitochondrial apoptosis, pro-apoptotic members translocate from the cytoplasm to the 
mitochondria where bind to anti-apoptotic Bcl-2 members to antagonize their function. 
In response to apoptotic stimuli, pro-apoptotic Bak and Bax undergoes series of 
structural changes that triggers insertion of these proteins into the mitochondrial 
membrane which leads to a lipidic pore formation and then increases mitochondrial 
membrane permeability that allows release of apoptogenic proteins such as cytochrome 
c (Antonsson et al., 2001; Mikhailov et al., 2003) 
 
Pro-apoptotic Bad could be regulated by phosphorylation where survival signals 
induce its phosphorylation on serine residues (Ser-112, Ser-136 and Ser-155) that leads 
to the sequestration and inactivation of Bad by 14-3-3 proteins (Datta et al., 2002). 
 
1.2.2 Oxysterols-induced apoptosis and associated signaling pathways 
 
 The increasing numbers of in vitro studies have described the potential pro-
apoptotic effect of oxysterols in various cell types including smooth muscle cells, 
fibroblasts, endothelial cells and macrophages. Among the different oxysterols, 27-
hydroxycholesterol 7-ketocholesterol, 7-hydroxycholesterol and 25-
hydroxycholesterol have shown to induce apoptosis on these given cell systems (Ares et 
al., 1997, 2000; Clare et al., 1995; Lemaire-Ewing et al., 2005). 
 
 With regard to extrinsic pathway of apoptosis, Lee and Chau showed that both 
7β- hydroxycholesterol and 25- hydroxycholesterol induced apoptosis while up-
regulating the levels of both Fas and Fas ligand (FasL) and their corresponding mRNAs 
in vascular smooth muscle cell (Lee and Chau, 2001). Moreover, Rho et al. 
demonstrated the effect of 7-ketocholesterol, using human aortic smooth muscle cells 
where the oxysterol predisposed cells to undergo cell death via Fas and TNF-α signaling 
pathway (Rho et al., 2005). 
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Numerous in vitro studies have demonstrated the involvement of mitochondrial 
pathway in oxysterols-induced cell death. In U937 human promonocytic cells, either 
treatment with 7or 7K induced apoptosis by activating caspase cascade, in 
association with loss of mitochondrial membrane potential. Luthra and colleagues 
confirmed the effect of 7K that activates caspases-3/7, -8, and -12 in human 
microvascular endothelial cells (Luthra et al., 2008). In a very recent study, Lizard et al. 
showed that U937 cells challenged with high concentrations of  7or 7K induced 
both extrinsic and intrinsic pathways of apoptosis in terms of activation of caspases  and 
degradation of cytosolic Bid (Prunet et al., 2005). In other experiments using 
macrophage lineage, 25-OH or 7,at final concentrations of 20-30 M or above 
induced apoptosis (Aupeix et al., 1995). Moreover, 7K (30 M) treatment induced pro-
apototic effects in  human promonocytic cells and murine J774A.1 macrophages (Biasi 
et al., 2004).  In relation to Bcl-2 family proteins regulation, Seye et al. showed that the 
levels of Bax protein upregulated and translocated from cytosol to mitochondria to 
induce cytochrome c release, in rabbit aortic smooth muscle cells treated with 7K (Seye 
et al., 2004). Indeed,  this oxysterol-induced transmembrane potential loss can be 
normalized upon removal of 7K after 16 h. Research carried out by Berthier et al. 
demonstrated the involvement of several signaling pathways in THP-1 cells in response 
to 7K-induced apoptosis (Berthier et al., 2005). Namely, Smac/DIABLO was released 
into the cytosol following oxysterol treatment with a subsequent depolarization of the 
mitochondria and cytochrome c release. Moreover, release of both Smac/DIABLO and 
cytochrome increased by inhibition of ERK1/2 in response to 7K treatment. Conversely, 
7K treatment for 24 h induced apoptosis along with increased level of phosphorylation 
of ERK1/2, JNK and p38 MAPKs in THP-1 cells (Palozza et al., 2007). In addition 
MAPKs, some in vitro studies observed the phosphorylation status of Akt pathway 
along with oxysterol-induced apoptosis. In this relation, 25-OH was observed to induce 
apoptosis through inhibition of Akt in murine macrophage-like cell line (Rusiñol et al., 
2004). More recently, Lordan et al demonstrated that 7 induced apoptosis caused 
degradation of Akt in U937 cells (Lordan et al., 2008). 
 
Taken together, these results suggest that oxysterols are able to active both 
intrinsic and extrinsic pathways of apoptosis with the involvement of MAPKs and other 
signaling pathways in various vascular cells. 
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1.3 Survival Signaling 
 
Intercellular communication is a crucial process in all of life forms, especially in 
multicellular organisms. Growth factors, defined as polypeptides and act as signaling 
molecules that regulate diverse biological processes such as cellular growth, 
proliferation, differentiation, and migration through the binding to receptors on the 
surface of their target cells (Bafico and Aaronson, 2003). Many growth factors bind to 
and activate receptors with intrinsic protein kinase activity. These receptor tyrosine 
kinase (RTK) family receptors contain an extracellular ligand binding domain, a 
transmembrane region and an intracellular part that contains a catalytic domain with 
kinase activity and several regulatory tyrosines, which are modified through auto- or 
trans-phosphorylation (Bafico and Aaronson, 2003; Perona, 2006). There are many 
different RTK classes have been identified such as epidermal growth factor (EGF), 
vascular endothelial growth factor (VEFG), fibroblast growth factor (FGF) and platelet-
derived growth (PDGF) which are important in pathological conditions including 
atherosclerosis and cancer (Raines and Ross, 1996; Witsch et al., 2010). 
Kinase activation through the binding of growth factors to their receptors  is 
mediated  by receptor dimerization where ligand binding stabilizes interactions between 
adjacent cytoplasmic domains (Perona, 2006). This event results in autophosphorylation 
of tyrosine residues located at the cytoplasmic tail of the RTK and also phosphorylation 
of relay proteins that each can trigger a separate cellular response. Activation of 
receptor signaling constitutively initiates multiple signal transduction pathways. The 
three best characterized signaling pathways activated in response to RTKs are the 
mitogen-activated protein kinase cascades (MAPKs), the lipid kinase 
phosphatidylinositol 3 kinase (PI3K) and  the phospholipaseC (PLC) pathway (Katz et 
al., 2007). Survival signaling pathways are summarized in Figure 1.4. 
1.3.1 Mitogen-activated protein kinases  
 
Cells can sense and respond to stress in various ways including initiation of cell 
death and promoting cell survival. There are many different types of response to stress 
that depends on the type, strength and duration of the stimuli and involves a complex 
network of signaling pathways. Several molecular pathways have been defined to 
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regulate the cell survival and cell death pathways. Among these pathways mitogen-
activated protein kinases (MAPKs), a group of proline-directed serine/threonine 
kinases, are the best characterized signaling pathways (Arciuch et al., 2009). MAPKs 
regulate stress signals in a three layer cascade fashion with a MAP kinase kinase kinase 
(MAPKKK) phosphorylating and activating its substrate MAP kinase kinase (MAPKK) 
which are dual-specificity kinases and then phosphorylates serine and threonine 
residues in their substrate, a MAP kinase (MAPK) (Trachootham et al., 2008). 
 
In mammals, three district cascades of MAPKs have been elucidated: 
extracellular signal-regulated kinases 1/2 (ERK 1/2), c-Jun N-terminal kinase/stress 
activated protein kinase (JNK/SAPK), and p38. These kinases are crucial for many 
biological processes and each pathway is regulated by distinct stimuli. Activation of 
JNK and p38 by oxidative stress and inflammatory cytokines are generally associated 
with initiation of apoptosis and cell cycle arrest. In contrast, ERK cascade is generally 
activated by G-protein coupled receptor ligands and growth factors, and regulates 
proliferation, survival, and differentiation signals (Matsuzawa and Ichijo, 2005). 
The ERK1 and ERK2 are widely expressed in human tissues and have  great 
research interest because of their critical involvement in broad array of cellular 
functions including cell cycle progression, proliferation, cytokinesis, transcription, 
differentiation, senescence, cell death, migration, learning and oncogenic transformation 
(Shaul and Seger, 2007). ERK1/2 signaling pathway is initiated by various-stress 
inducing stimuli including growth factors, viral infections, carcinogens and mitogens 
and this activation involves the Ras-Raf-ERK cascade. In depth, ligand binding of 
RTKs leads to GTP (guanosine triphosphate) loading and activates a small G protein, 
namely Ras which recruits the serine/threonine kinase, Raf (MAP-KKK) to the plasma 
membrane where it is activated, and sequentially phosphorylates and activates MEK1/2 
and ERK1/2 (Ramos, 2008). 
 
JNK is encoded by three genes, termed JNK1, JNK2 and JNK3 (also known as 
SAPKγ, SAPKα, and SAPKβ, respectively) and these genes alternatively spliced 
resulting in 10 or more JNK isoforms (Arciuch et al., 2009). JNK1 and JNK1 are 
ubiquitously expressed whereas JNK3 is present in the brain, heart and testis. JNK 
signaling cascade regulate cell death and the development of multiple cell types in the 
immune system, whereas JNK1 and JNK1 deficient mice are immunodeficient due to 
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severe defects in T cell function (Tournier et al., 2000).  JNK activation is initiated by 
stress conditions such as ionizing radiation, heat shock, DNA damage and inflammatory 
cytokines.  JNK phosphorylation is catalyzed by two protein kinases MKK4 (SEK1) 
and MKK7 which are dual specifity kinases and selectively phosphorylate JNK on Tyr 
and Thr, respectively (Davis, 2000). JNK translocates to the nucleus where it 
phosphorylates and upregulates several transcription factors, including c-Jun, JunA, 
JunB, activating transcription factor (ATF)-2 and Elk-1 (Katz et al., 2007). 
The p38 kinase family consist of four members namely α, β, γ and δ and these 
enzymes activated by hormones, cytokines, G protein-coupled receptor ligands and 
cellular stress (Arciuch et al., 2009). Activation of p38 kinases is mediated by the 
MKK3 and MKK6 kinases, and following the activation, p38 phosphorylates its 
substrates including MAPK interacting kinases Mnk 1 and Mnk 2, and eukaryotic 
initiation factor 4e (eIF4e) (Roux and Blenis, 2004). Many studies have shown that p38 
MAP kinases have critical role in signal transduction of immune and inflammatory 
responses. In addition, they are also involved in the regulation of angiogenesis, cytokine 
production, cell death and proliferation (Arciuch et al., 2009; Katz et al., 2007). 
The crucial role of MAPKs in controlling gene expression, cell growth, 
differentiation and apoptosis has made them a priority for research whereas deregulation 
of these MAPKs activity can result in many diseases and cancer. Thus MAPKs 
including ERK, JNK, and p38 are all molecular targets for drug development, and 
pharmalogical manipulation of these kinases will likely help for the treatment of human 
disease related to disproportionate apoptosis. 
 
1.3.2 PI3K-PKB/Akt 
 
The PI3K/Akt pathway has been established as one of the most critical signaling 
pathway in regulating cell survival. PI3K is a heterodimeric enzyme composed of two 
subunits, namely the p85 regulatory subunit and the p110 catalytic subunit. PI3K 
activation can be stimulated by binding of its p85 regulatory subunit to an activated 
receptor (Katz et al., 2007). Alternatively, phosphorylation of RTKs can also stimulate 
the activation of PI3K cascade, resulting in recruitment of PI3K to the plasma 
membrane. Following the activation, PI3K converts the phosphatidylinositol (3,4)-
bisphosphate (PIP2) lipids to phosphatidylinositol (3,4,5)-trisphosphate(PIP3) which is 
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a second messenger that recruits 3-phosphoinositide-dependent protein kinase 1 (PDK1 
and Akt (also known as protein kinase B, PKB) to the plasmamembrane (Arciuch et al., 
2009; Cantley, 2002). Consequently, the PDK1 phosphorylates and activates Akt that 
results in subsequent phosphorylation of various substrate proteins, including caspase-9, 
Mdm2, glycogen synthase kinase 3 (GSK3) and forkhead transcription factor 
(FKHRL1), which targets FasL, Bim, IGFBP1, and Puma. A large amount of evidence 
has suggested that BAD is one of the direct targets of Akt in promoting cell survival 
that phosphorylation of BAD on Ser
136
 by Akt  prevents to exhibit pro-apoptotic activity 
of BAD in cells (Song et al., 2005; Trachootham et al., 2008). 
 
Akt can also exert its anti-apoptotic functions by phosphorylating IKK and 
cyclic AMP response element–binding protein CREB that results in elevated 
transcription of genes encoding Bcl-2, Bcl-xl, and Mcl-1 anti-apoptotic proteins. ASK1 
is also reported as target of Akt that Akt-mediated phosphorylation of ASK1 inhibited 
its ability to activate JNK/p38 and prevented stress-induced apoptosis. Thus, it can be 
suggested that there is a cross talk between the PI3K-Akt and ASK1-JNK pathways in 
the regulation of cell survival (Matsuzawa and Ichijo, 2005; Song et al., 2005; 
Trachootham et al., 2008). Akt is activated by site-specific phosphorylation at two 
regulatory sites, Thr
308
  in the activation loop and Ser
473 
in the carboxy-terminal (C-
terminal) tail while phosphorylation of both sites is required for full activation (Arciuch 
et al., 2009). 
1.3.3 Protein kinase C 
 
Phospholipase C- γ (PLCγ) activation is stimulated by G protein coupled 
receptors (GPCRs) that interact with G proteins of the Gq family. Active PLCγ enzyme 
catalyzes the hydrolysis of PIP2 to produce inositol 1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG). Binding of  IP3 receptors on the membrane of the endoplasmic 
reticulum (ER) causes the release of intracellular Ca
2+
 which is followed by the 
activation of protein kinase C (PKC) family members (Katz et al., 2007; O’Gorman and 
Cotter, 2001).  
 
The PKC is a ubiquitous family of serine/threonine kinases and has at least 10 
members containing a highly conserved kinase core at the C-terminal and an amino-
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terminal auto inhibitory pseudosubstrate peptide. PKC isoforms can be subdivided into 
three subfamilies according to their structural differences in isoenzyme regulatory 
domains. Conventional/classical PKC isoforms (α, β1, β2 and γ) are regulated by both 
Ca
2+
 and DAG; the novel isoforms (δ, ε, 𝛉 and ε) contain DAG-sensitive C1 domains 
but Ca
2+
-insensitive C2 domain while the atypical PKCs (δ and ι) regulation both Ca2+ 
or DAG -independent.  PKC isoforms play diverse role in signal transduction, 
mediating cell proliferation, differentiation, death, mitogenesis and stress responses 
(Arciuch et al., 2009; Guo et al., 2004). Most of the family members have been shown 
to contribute to cell survival whereas; novel members such as PKC α and PKC δ have 
been associated with apoptosis induction through inhibition of the PKB/Akt survival 
pathway and activation of p38 MAPK (Matsuzawa and Ichijo, 2005; Yang et al., 2008). 
 
Figure 1.4. Survival signaling pathways. 
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1.4 Oxysterol -induced survival and associated pathways  
 
Over the last decade, numerous in vitro studies have characterized the potential 
pro-apoptotic effect of oxysterols in variety of cells. It has been long accepted that 
apoptosis induced by oxysterols has been strongly related with the potential toxicity and 
pathogenic implication of these molecules in chronic diseases including atherosclerosis 
and common neurodegenerative diseases. Of note, an increasing bulk of studies is 
giving evidence of the involvement of the oxysterols in the modulation of cell survival 
signals.  
 
Based on the presently available data, oxysterols have differences in the degree 
of cytotoxicity and ability to induce cell death, but these cellular effects of oxysterols 
have been mostly studied singularly. However, oxysterols are always present in oxLDL, 
foods and the core region of atherosclerotic plaques as a mixture and literature about the 
way in which oxysterols act collectively is limited.  In this connection, a very 
interesting point has been shown by Biasi et al., namely the cytotoxicity of single 
oxysterol is quenched when cells challenged with the oxysterol mixture (Biasi et al., 
2004). In particular, murine macrophages  treated with 7-ketochosterol (7K) undergo 
apoptosis along with mitochondrial pathway, whereas the same cells are co-treated with 
equimolar concentrations of 7beta-hydroxycholesterol (7-OH), the pro-apoptotic effect 
of single oxysterol was markedly attenuated. Notably, 7K-induced intracellular ROS 
rise through NADPH oxidase activation had been inhibited by the oxysterol mixture, 
suggesting that a substrate-based competition among oxysterols at the level of NADPH 
oxidase,  (7-OH binds to NADPH oxidase less efficiently than 7K, may reduced the 
concentration of free enzyme available for 7K binding) attenuated ROS production and 
direct toxicity (Biasi et al., 2004; Leonarduzzi et al.). In agreement with this,  Aupex et 
al. showed that the challenge of U937 human promonocytic cell line with 7-OH (30-40 
M) alone was exerting pro-apoptotic effect, significantly diminished with the addition 
of identical amount of 25-hydroxycolesterol (25-OH) (Aupeix et al., 1995).  
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1.4.1 Regulation of cell survival at the signal-transduction level 
 
Growing evidence points to activation of survival signaling pathways such as 
MAP kinases, PKC, PI3K/Akt by oxysterols, depending on their concentration and the 
exposure time. The first evidence of the involvement of oxysterols in cell survival was 
demonstrated by Berthier and colleagues, in an in vitro study challenging THP-1 human 
monocytic cells with a high concentration of 7K (100 M)  which is one of the most 
abundant oxysterol with a strong pro-apoptotic effect (Berthier et al., 2005). 
Challenging that cell line with7K leading to the activation of MEK/ERK signaling 
pathway followed by inactivation of pro-apoptotic protein Bad, thereby delaying the 
apoptotic mechanism initiated by 7K itself. More recently, another group performed 
experiments on other human promonocytic cell line (U937), with low micromolar 
concentration of 27-hydroxycholesterol (27-OH), produced results showing a significant 
induction of cell viability through triggering the phosphorylation of  Akt at residue 
Thr308 that delayed apoptotic death whereas high concentrations of 27-OH triggered 
lysosomal-independent apoptosis (Riendeau and Garenc, 2009). Moreover, Akt-
dependent survival signaling induced by 27-OH is impaired when higher concentrations 
of the same oxysterol is applied suggesting that the effect of the oxysterol on 
macrophagic cells appeared to depend on the concentrations used. Again using low 
doses of an oxysterol, this time treating human cholangiocyte MMNK-1 cells with 
cholestan-3β,5α,6β-triol (Triol), Jusakul et al. showed that activation of pro-survival 
signaling including ERK1/2 and p38 α phosphorylation were found in Triol-exposed 
cells (Jusakul et al., 2013). In agreement with these results, another oxysterol, 7-OH 
has been shown as anti-apoptotic and induced cell proliferation when added at low 
concentrations (below 20 μg/ml) to human umbilical-vein endothelial cells (HUVEC); 
this effect is dependent on the activation of MEK/ERK cascade, but independent of 
ROS production (Trevisi et al., 2009). However, at higher concentrations 7-OH 
induces HUVEC's apoptosis suggesting that oxysterol treatment had a dual effect on 
endothelial cell viability, depending on the concentration. 
 
Most likely, oxidized low density lipoprotein (oxLDL ) has been shown to exert 
similar effects with oxysterols that oxLDLs have a dual effect on cell viability, 
proliferation or inducing apoptosis in endothelial cells (Galle et al., 2001). This dual 
effect is dependent on the concentrations of the oxLDL; at low concentrations (5-10 
23 
 
μg/mL) they induce a proliferative effect, while at high concentrations (50-300 μg/mL) 
they induce cell death. Moreover, NADPH oxidase dependent ROS increase is involved 
in both effects (Galle et al., 2001; Heinloth et al., 2000).  
 
In the context of oxLDL induced proliferation, another research group 
challenged cultured bone marrow derived macrophages with oxLDL in the 1.56-200 
μg/ml concentration range and showed the activation of both ERK1/2 and PKB kinases 
and subsequent phosphorylation of Bad and IkBa which are the pro-survival targets of 
PKB (Hundal et al., 2001). Indeed, only PI3K/PKB survival pathway is involved in 
oxLDL’s anti-apoptotic effect against macrophage colony-stimulating factor (M-CSF) 
with drawal where prevention of MEK pathway by PD98059 and U0126 inhibitors did 
not diminish cytokine-independent macrophage survival. Conversely, in another study, 
THP-1 monocytic cell line was challenged with an oxLDL final concentration of 50 
μg/ml, it was reported that oxLDL attenuates staurosporine-induced apoptosis by 
activating ERK signaling pathway whereas PI3K/Akt activation was not involved in cell 
protection by the compound (Namgaladze et al., 2008).  Similarly, in a very recent 
study the neuroprotective effect of 27- and 24-hydroxycholesterol have been shown in 
human neuroblastoma SH-SY5Y cells against staurosporine-mediated apoptotic events 
(Emanuelsson and Norlin, 2012).  
 
Since oxLDL induced macrophage proliferation and survival was linked to 
activation of pro-survival signaling pathways; however, little is known regarding the 
upstream signaling events including the pattern recognition receptors. In this relation, 
Riazy et al. have recently demonstrated that oxLDL-mediated survival of bone marrow 
derived macrophages involves  PI3K signaling pathway whereas none of the pattern 
recognition receptors including endocytic pattern recognition receptors (PRRs), 
scavenger receptor A (SR-A) and CD36 are essential for activating the anti-apoptotic 
effect of oxLDL which is not dependent on the uptake of oxLDL (Riazy et al., 2011). 
It thus appears that both MEK/ERK and PI3K/Akt signaling pathways have critical role 
in the pro-survival effect of modified lipoproteins whereby the balance between anti-
apoptotic pathways (ERK, Akt)  and stress-activated pro-apoptotic pathways (JNK,p38) 
would determine the final effect: cell survival or apoptosis. In this relation, Anticoli et 
al. demonstrated that liver-derived cells challenged with physiological concentrations of 
7K and 5,6-secosterol (5,6-S), a recently discovered oxysterol, elicits low 
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concentrations of 5,6-S had a pro-proliferative effect inducing ERK1/2 activation not 
counterbalanced by p38 MAPK and/or JNK pathways (Anticoli et al., 2010). Indeed, 
Nox-4 mediated 7KC-induced apoptosis in human aortic smooth muscle cells (SMCs) 
involved JNK/AP-1 signaling pathway (Pedruzzi et al., 2004). However, Ares and 
colleagues showed that the effects induced by 7-OH involved ERK1/2 signaling but 
not JNK in human aortic smooth muscle cells (Ares et al., 2000). Interestingly, a 
significant increase of cytosolic Ca
2+
 as induced by oxysterol itself was observed in 
smooth muscle cells with 24.8μM of 7-OH. In addition to this, several lines of 
evidence also suggest that increase of cytosolic free Ca
2+
 involved in pro- and anti-
apoptotic signaling triggered by oxysterols. Firstly, Lizard and colleagues demonstrated 
that 7K-induced THP-1 cell apoptosis is triggered by a sustained influx of extracellular 
Ca
2+ 
which elicits the activation of calcineurin (PP2B) leading to apoptosis through 
dephosphorylation of the pro-apoptotic Bad protein (Berthier et al., 2004). Moreover, 
the activation of calcium-dependent calcineurin is induced by translocation of transient 
receptor potential calcium channel 1 (Trp-1), a component of the store-operated Ca
2+ 
entry channel, into lipid raft domains of the plasma membrane. Indeed, the same group 
also showed the involvement of calcium-dependent activation of MEK/ERK survival 
pathway via calcium-sensitive proline rich tyrosine kinase (PYK-2) during 7K-induced 
apoptosis, as mentioned in the first paragraph (Berthier et al., 2005). In the context of 
oxLDL induced macrophage proliferation, it has been reported that an increase in 
intracellular Ca
2+
is required for the pro-survival effect of oxLDLs (Matsumura et al., 
1997). More recently, to clarify the downstream pathways that are activated by the 
increase Ca
2+
, bone marrow derived macrophages was challenged with oxLDL; it was 
observed that oxLDL can prevent macrophage apoptosis by mobilizing calcium which 
is followed by the activation of the Ca
2+
-sensitive eukaryotic elongation factor-2 (eEF2) 
kinase through inhibiting its negative regulation by blocking p38 MAPK 
phosphorylation (Chen et al., 2009).  
 
According to the available literature on oxysterol-induced pro-survival signals it 
can be suggested that, in general terms, this is a complex phenomenon depending on the 
cell type, environmental factors, cell senescence, oxysterol concentration and exposure 
time. Notably, when relatively low and not directly toxic concentrations of oxysterols 
are applied or administered in a biologically representive mixture; this is, incidentally, a 
more realistic approach,  they exert a “Trojan-horse” like behaviour (Biasi et al., 2004; 
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Vurusaner et al., 2014). Namely, instead of killing the cell directly, oxysterols might 
delay its irreversible damage, in the meantime initiating pro-inflammatory and pro-
fibrogenic pathways while relatively higher amounts induce earlier and direct cell death. 
Be this it may, through the uptake of modified LDL, toxic levels may exist even in LDL 
that is taken up by normal LDL receptors, then they may cause damage, once properly 
concentrated and metabolized (Leonarduzzi et al., 2002). Moreover, it can be suggested 
that delayed macrophage apoptosis would favor growth and destabilization of advanced 
atherosclerotic plaques (Martinet et al., 2012). Thus, understanding the molecular 
mechanism underlying the relationship between signal transduction pathways including 
protein kinases and oxysterols-induced pro- and anti-apoptotic signaling pathways 
might contribute to a better understanding of several oxysterol-associated diseases. 
 
 
1.4.2 Regulation of cell survival at the transcription level 
 
Increasing evidence indicated the existence of a redox regulation for many 
signaling proteins such as MAP kinases, PKC, PI3K/Akt and several transcription 
factors that their modulation leads to cell cycle changes and integration of pro- and anti-
apoptotic signals. These redox-sensitive transcription factors include Nrf2, NF-kB, 
Jun/AP-1 and p53 that have key roles in cell survival or death decision (Trachootham et 
al., 2008). AP-1 and p53 are involved in both the induction and prevention of cell death 
according to circumstances whereas Nrf2 and NF-kB activation mostly lead to cell 
proliferation and survival. Moreover, p53 affects cell survival at all three levels 
including transcription, signal transduction and execution through crosstalk among 
them. In general terms, they regulate cell survival through altering transcription of 
multiple genes whereby activation of these transcription factors by stimuli such as 
cytokines or oxidative stress lead increased expression of pro- or anti-apoptotic 
proteins.  
 
At the moment, little is known on the molecular mechanisms involved in 
oxysterol-induced survival pathways at the transcriptional level while information on 
the involvement of protein kinases have increased greatly. In section 1.3, the oxysterol-
mediated activation of transcription factors was reported in detail. In addition to this, 
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throughout this thesis we focused on the redox sensitive Nrf2 pathway which plays a 
critical role in protection against oxidative/electrophilic stress generated from exposure 
to exogenous and endogenous chemicals including lipid peroxidation products and 
promotes cell survival. Although Nrf2 appears to be one of the major cellular defense 
pathway, the studies on Nrf2 regulated downstream pathways remain limited, thus 
understanding the regulatory mechanisms may contribute to drug resistance induced by 
Nrf2 to immoderate protection from anti-cancer treatments (Niture et al., 2010). 
 
1.4.3 Nrf2 signaling pathway  
 
Nrf2 (nuclear factor E2-related factor 2), a member of the Cap’n’Collar family 
of b-Zip transcription factors and p45 NF-E2–related proteins, has been identified as a 
key mediator of the antioxidant genes activation through the antioxidant response 
element (ARE) (Nguyen et al., 2003). Under normal conditions, Nrf2 is sequestered in 
the cytoplasm through interacting with  Kelch-like ECH-associated protein 1 (Keap1), 
an actin-binding cytoskeletal protein (Motohashi and Yamamoto, 2004). Under 
oxidative stress Nrf2 dissociates from Keap1, then also from cytoskeleton, and migrates 
into the nucleus where it heteromerizes with Mafs and binds to ARE sequences, 
codifying for antioxidant enzymes including aldoketoreductase, glutathioneperoxidase 
(GPx), glutathione reductase (GSR), heme oxygenase-1 (HO-1), and NAD(P)H:quinone 
oxyreductase (NQO-1) (Dinkova-Kostova, 2002; Dinkova-Kostova et al., 2001; Iqbal et 
al., 2003; Nguyen et al., 2009) (Fig.1.5.). Although growing evidence showed that the 
protective adaptive response to ROS/RNS is mediated by enhanced expression of these 
cytoprotective enzymes, the specific upstream signal transduction pathways used to 
activate transcription of these phase II genes are poorly defined (Lee and Choi, 2003; 
Mann et al., 2007). In this relation, recent studies demonstrated the clear involvement of 
several protein kinase pathways including the ERK 1/2, JNK,p38 and PKC in the 
phosphorylation and stabilization of Nrf2 to facilitate its nuclear translocation and 
binding to ARE sequences of target genes (Anwar et al., 2005; Yu et al., 2000). 
27 
 
 
Figure 1.5. General scheme for the induction of Nrf2-ARE signaling pathway. (Lee and 
Johnson, 2004) 
 
1.4.3.1 Nrf2 antioxidant pathway and lipid oxidation products 
 
Recent studies in oxLDL-treated vascular cells demonstrated the activation of 
the transcription factor Nrf2 by components of oxLDL that points to the involvement of 
this antioxidant response element in the signaling pathway sustaining atherosclerosis 
progression (Ishii et al., 2004). In the same study, they provided the first evidence that, 
oxLDL activates PPAR-γ and controls expression of scavenger receptor CD36 in 
macrophages suggesting that Nrf2 is a key regulator in the oxLDL uptake by the 
vascular wall and induction of antioxidant stress genes in atherosclerosis. Moreover, 
oxLDLs were shown to activate Nrf2 much strongly in murine macrophages than in 
smooth muscle cells, while 4-hydroxynonenal (HNE), a major product of oxidized 
lipids was equally stimulating Nrf2 translocation to the nucleus in both cell types, by 
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this way suggesting that modulation of Nrf2 response could much depend on the type of 
chemical inducer and the type of cell. In a very recent study, C6 glioma cells challenged 
with 10 or 20 μM 27-OH to observe the role of this oxysterol in the modulation of Nrf2 
in neurodegenerative diseases including AD, Alzheimer’s disease (Ma et al., 2015). 
Observations showed that the down regulated expression of Nrf2 and its down-stream 
antioxidant genes HO-1, NQO-1 and γ -GCS at both of gene and protein levels in 
response to 27-OH which is neurotoxic and pro-oxidant in astrocyte cells.  
 
A number of reports have addressed Nrf2-target genes such as HO-1 and NQO-1 
that are critical in the cellular response against pro-oxidative stimuli including oxidized 
LDL and oxidized phospholipids, result to be expressed in all main cell types present in 
mouse and human atherosclerotic lesions, such as macrophages, endothelial cells, and 
smooth muscle cells (Araujo et al., 2012). In this relation, the oxidized phospholipid ox-
PAPC was shown to induce HO-1,NQO-1 and GCLM expression in endothelial cells in 
a Nrf2-dependent manner (H. K. Jyrkkänen et al., 2008). Similarly, HO-1 induction via 
Nrf2 signaling pathway was demonstrated in vascular smooth muscle cells in response 
to moderately oxidized LDL (Anwar et al., 2005). Moreover, induction of this 
cytoprotective response includes HO-1 up-regulation implied the activation of PKC and 
MAPK pathways including p38, JNK and ERK1/2. Besides activation of MAPKs by 
lipid oxidation products modulates smooth muscle cell proliferation, evidence relating 
the involvement of these signaling pathways in the induction of Nrf2 antioxidant 
response is limited (Velarde et al., 2001; Yang et al., 2001). 
 
Recent studies have implicated that Nrf2 translocation to the nucleus is 
modulated by ERK1/2, p38 MAPK, PKC and PI3K/Akt pathways, however the 
intensity of these upstream signals that control Nrf2 nuclear transposition varies with 
the different inducers in the different cell types. Regarding this, Papaiahgari and 
colleagues showed that ROS-dependent anti-apoptotic ERK and Akt activation 
regulates Nrf2-mediated transcription by favoring translocation of Nrf2 from cytoplasm 
to the nucleus in response to hyperoxia in pulmonary epithelial cells (Papaiahgari et al., 
2006, 2004).  Collectively, these studies indicate that Nrf2 transcription factor has an 
important role as downstream effectors of PI3K signaling pathway to regulate 
transcription against hyperoxia that contribute to cell survival. Another study has also 
shown that survival signaling pathway PI3K/Akt-dependent Nrf2 protein increase and 
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HO-1 expression up-regulation in PC12 pheochromocytoma cells (Martin et al., 2004). 
HNE-mediated induction of HO-1 mRNA and protein have been postulated in 
macrophages and epithelial cells involving the activation of ERK survival pathway 
suggesting that HO-1 induction is an adaptive response to oxidative stress (Iles et al., 
2005; Li et al., 1996).  Contrary results were reported in hepatoma cells challenged with 
defined metabolites of the prostaglandin J(2) series in which activation of HO-
1synthesis was not quenched by the ERK1/2 inhibitor PD98059, suggesting that up-
regulation of this heme catabolism-related enzyme might be obtained through more than 
a single signaling pathway (Liu et al., 2004). More recently, the anti-apoptotic effect of 
the same compound was demonstrated in rat pheochromocytoma cells showing that 
Nrf2 activation and subsequent HO-1 induction involving survival ERK and Akt 
pathways to protect cells against oxidative-stress induced cell death (Kim et al., 2008). 
Therefore, based on the presently available data, the switch on or off of Nrf2 by 
different types of inducers including lipid oxidation products leads to cell survival and 
protection against oxidative stress whereas reduced apoptosis may result in 
tumorigenesis and drug resistance (Niture and Jaiswal, 2012). 
 
1.5 Oxysterols in the pathogenesis of major chronic diseases 
 
In the years of predominant biochemistry approach to the role played by various 
members of the oxycholesterol family in humans, oxysterols have been mainly 
investigated for their physiological role played in the synthesis of bile acids and steroid 
hormones, in the sterol transport and metabolism, in gene regulation. But evaluating the 
biochemical effects of cholesterol oxidation products it appeared quite evident the 
strong pro-inflammatory, pro-apoptotic and pro-fibrogenic properties of some of them 
(Sottero et al., 2009). Over the last few years, effectively supported by a molecular 
biology-based technology, the molecular aspect of such a pro-inflammatory effect of 
oxysterols has been well deepened, and a still growing bulk of experimental findings 
strongly points to a significant contribution paid by these cholesterol derivatives to the 
progression of inflammatory-based chronic pathologies. 
 
Among the very common human diseases that recognize hypercholesterolemia as 
primary risk factor and are associated with inflammation are vascular aging, 
atherosclerosis and cardiovascular accidents, Alzheimer’s disease as well as multiple 
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sclerosis, inflammatory bowel disease and colorectal cancer, non alcoholic liver disease 
and retinopathies, diabetes mellitus, etc. (Biasi et al., 2013; Gamba et al., 2011; Poli et 
al., 2013).  Cholesterol oxidation products have been shown to be involved in various 
key stages of atherosclerosis where promising therapeutic strategies targets oxysterol 
elimination in different stages of this disease; we will especially focus on 
atherosclerosis throughout this thesis. 
 
1.5.1. Atherosclerosis 
 
The World Health Organization emphasized the importance of scientific 
research into atherosclerosis which is the leading cause of mortality in developing 
countries. Atherosclerosis is the principal contributor to some serious diseases including 
heart diseases, myocardial infarction and stroke affecting numerous people (McLaren et 
al., 2011). Atherosclerosis is a multifactor chronic inflammatory disease characterized 
by the accumulation of lipid and cholesterol within the intima of large and medium 
sized arteries (Lusis, 2000). Atherosclerotic early lesions develop from an initial fatty 
streak, which progress by endothelial dysfunction, expression of adhesion molecules, 
further inflammatory processes including infiltration of the monocytes under the 
endothelium where these monocytes differentiate into macrophages and consequent 
engulfment by macrophages leads to formation foam cells which is the most 
characteristic hallmark of the atherosclerosis (Crowther, 2005; Kutuk and Basaga, 
2003). Many biological processes including migration, cell proliferation and apoptosis 
contribute to the progression of atherosclerotic lesion. Migration of vascular smooth 
muscle cells from the media results in synthesis of collagen to surround the lipid laden 
macrophages formed lipid cores with a protective fibrous cap. In advanced lesions with 
a large lipid core which contains both the necrotic and apoptotic cells thus become 
highly instable, are prone to rupture. The rupture of the fibrous plaque usually occurs at 
the shoulder region of the lesion, which is followed by thrombus formation that cause 
symptoms of acute coronary syndromes and stroke (Martinet and Kockx, 2001; Shibata 
and Glass, 2010). The pattern of atherosclerotic lesions development can be described 
into two main phases. The first phase includes perturbations in endothelial functions and 
inflammation stimuli that provoke the release of cytokines and proliferative response for 
smooth muscle cells, subsequent intimal migration and intima formation. It has been 
suggested that apoptosis has a role in development of lesions through initiating 
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extensive endothelial cell turnover leading to endothelial dysfunction (Endemann and 
Schiffrin, 2004). Thus, it seems that apoptosis contribute to the first phase of 
atherosclerotic lesions formation targeting two cell types including proliferative 
stimulation for vascular smooth muscle cells. In the second phase of lesion progression 
the formation of oxidized low density lipoproteins occurs in the vascular wall while 
inflammatory response increases. It also includes the accumulation of free radicals with 
alteration of redox balance and modification of lipids, proteins and DNA which results 
in plaque development and stabilization by extracellular matrix (Robbesyn et al., 2004; 
Tabas, 2009). In the following, advanced lesions with extensive apoptosis of cells leads 
to fibrous cap thinning thus plaque destabilization, rupture and thrombosis (Dimmeler 
and Zeiher, 2004; Stoneman and Bennett, 2004). In Figure 1.6., a schematic 
representation of the main events involved in the remodeling of arterial vessels in 
atherosclerotic process and the contribution made by cholesterol oxidation products in 
each step of this process was illustrated. 
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Figure 1.6. Schematic diagram of the vascular remodeling due to atherosclerosis. (Poli et 
al., 2009) 
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1.5.2. Oxysterols and Atherosclerosis 
 
 Increasing number of experimental studies have revealed that oxysterols are 
major compounds of favoring the development of atherosclerosis and play crucial role 
in various stages of the atherosclerotic process including endothelial dysfunction, 
smooth muscle cell proliferation, leucocyte adhesion and platelet aggregation. 
 
 Among side-chain cholesterol oxidation products, 27-OH is the major oxysterol 
implicated in advanced atherosclerotic lesions. In addition, 7K and 7-OH are thought 
to have high pro-atherogenic potential which comprise 75% of all oxysterols found in 
atherosclerotic plaques from different sites (Khatib and Vaya, 2014; Zarrouk et al., 
2014). It has been demonstrated that oxysterols can contribute endothelial dysfunction 
where 7K has upregulated the expression of proatherogenic actin-binding protein 
profilin-1 in aortic endothelial cells through activation of signal transducer and activator 
of transcription 3 (STAT3) (Romeo and Kazlauskas, 2008). 
 
 Another studies showed that oxysterols can contribute to monocyte 
differentiation and also foam cell formation which is the key process during the 
development of atherosclerotic lesions. In this relation, Hayden et al. demonstrated that 
7K favors monocyte differentiation through a sterol-mediated regulatory pathway and 
promotes foam cell formation in THP-1 cells (Hayden et al., 2002). Moreover, 7K could 
also contribute to fatty streak formation and induces production of pro-inflammatory 
molecules by M1 and M2 macrophage subsets (Buttari et al., 2013). Moreover, 7K as 
well as 7β-OH, and 5β,6β-epoxycholesterol can induce expression of adhesion 
molecules that contribute to monocyte accumulation at the sub-endothelial level (Vejux 
et al., 2008, 2007). These oxysterols can also induce endolysosomal phospholipidosis 
by triggering the formation of myelin figures with high levels of phospholipids. 
Regarding to this, an in vitro study showed that 7K-induced phospholipidosis involves 
downregulation of PI3K/Akt signaling pathway which is inhitable by vitamin E in U937 
cells (Vejux et al., 2009).  
 
Increasing evidence is accumulating of the pro-inflammatory effects of 
oxysterols on vascular cells that contribute to their pro-atherogenic role.  Various 
oxysterols including 7β-OH, 7K, 25-OH, 24-OH, and  TRIOL have been shown to 
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induce the expression of chemokines such as as monocyte chemotactic protein-1 (MCP-
1), inflammatory cytokines such as  interleukin-1 (IL-1) and interleukin-8 (IL-8) in 
vascular cells including monocytic, endothelial and smooth muscle cells (Erridge et al., 
2009; Lemaire-Ewing et al., 2009; Rydberg et al., 2003). Lemaire-Ewing and 
colleagues demonstrated that in THP-1 cells IL-8 is upregulated either by 7β-OH or by 
25-OH, was shown to be associated with Ca
2+
 influx and leading to of transcription 
factor activator protein-1 (AP-1) activation (Lemaire-Ewing et al., 2009). In recent 
studies, the crucial role of PKC and ERK1/2 signaling pathways in oxsyterol-induced 
cytokine inflammation was also reported (Poli et al., 2009). Induction of MCP-1 over-
expression has been reported in promonocytic U937 cells challenged with a biologically 
relevant mixture of oxysterols, involving activation of ERK1/2 pathway and increased 
nuclear translocation of NF-κB. Furthermore, 7α-OH was shown to upregulate both 
expression and synthesis of MCP-1 in macrophage cells (Leonarduzzi et al., 2005). The 
pro-fibrogenic activity of oxysterols was also studied in terms of modulation of 
transforming growth factor-β1 (TGFβ1) while mixture of oxysterols was shown to 
induce both expression and synthesis of TGFβ1 in murine macrophagic cells 
(Leonarduzzi et al., 2001). 
Based on the studies, it can be suggested that in early phases of atherosclerotic 
plaque development, the increase of oxidized cholesterol mixture might provoke pro-
inflammatory, proliferative and pro-fibrogenic stimuli rather than pro-apoptotic, thus 
leading a Trojan horse like effect (Hajjar and Haberland, 1997). Moreover, in advanced 
lesions, the pro-apoptotic effects exerted by oxysterol leads to their excessive 
accumulation and favors cap destruction. 
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2. AIM OF THE STUDY 
 
 
 
Oxysterols are a family of 27-carbon molecules and generated from cholesterol 
oxidation by both enzymatic and non-enzymatic mechanisms. A number of studies 
demonstrated the pro-apoptotic, pro-oxidant and pro-inflammatory effects of these 
compounds which likely contribute the development of variety pathophysiological 
processes. Accumulating evidence suggested that oxysterols are able to modulate not 
only death pathways but also anti-apoptotic signals in targeted cells; however, the latter 
matter has not yet been investigated in deep. The lack of published studies addressing 
the molecular mechanism underlying the survival response and adaptation stage against 
the low concentrations of these compounds has prompted our study. Thus, we have 
identified the aim of this thesis as such; to identify the main genes and related products 
involved in the transduction of survival signals and elucidate the relevant molecular 
mechanisms in human promonocytic cells (U937) challenged with low concentration of 
27-hydroxycholesterol (27-OH) by far the most represented oxysterol in human blood. 
Specifically, the aim was; 
i. to elucidate molecular mechanism of low concentration (10µM) of 27-
hydroxycholesterol induced early response (<24 h) survival/apoptosis delay, 
ii. to investigate the impact of both mitogen-activated protein kinase ERK kinase 
(MEK)/ERK and phosphoinositide 3-kinase (PI3K)/Akt signaling pathways on 
this survival mechanism, 
iii. to understand role of Bcl-2 family proteins whereby 27-OH may generate 
survival signals in cells of the macrophage lineage, 
iv. to clarify whether the pro-oxidant effect of 27-OH is involved in that survival 
response, 
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v. to identify the possible involvement of Nrf2 and antioxidant response in the 
prolonged cell survival in 27-OH treated cells. 
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3. MATERIALS AND METHODS 
 
 
 
 
3.1. Materials 
 
 
3.1.1. Chemicals 
 
 
All chemicals used in this study are listed in Appendix A. 
 
 
3.1.2. Antibodies and enzymes 
 
 
All antibodies and enzymes used in this study are listed in Appendix B. 
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3.1.3. Growth Media 
 
RPMI: U937 cell lines was maintained in filter-sterilized RPMI1640 medium 
(PanBiotechGmbH, Aidenbach,Germany) that is supplemented with 10% fetal bovine 
serum, 2mM L-Glutamine, 100 U/ml penicillin/streptomycin at 37ºC with 5% CO2. 
 
Freezing medium: U937 cell lines were frozen in heat-inactivated fetal bovine 
serum containing 10% DMSO (v/v). 
 
3.1.4. Mammalian Cell Lines 
 
U937: Human promonocytic cell line (ATCC® CRL1593.2 ™) 
 
3.1.5. Molecular Biology Kits and Reagents 
 
Molecular biology kits and reagents that are used for apoptosis screening and 
protein analysis are listed in Appendix C. 
 
3.1.6. Buffers and Solutions 
 
All buffers and solutions used in this study are listed in Appendix D. 
 
3.1.7. Primers 
 
The primers used in this study are listed in Table 3.1. 
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PRIMER NAME 
 
 
SEQUENCE 
 
 
COMPANY/C
ATALOG # 
 
Hs_NFE2L2 AAC TTG ATT GAC ATC CTT TGG AGG 
Qiagen/ 
QT00027384 
Hs_NQO1 CTC GCC TCA TGC GTT TTTG 
Qiagen/ 
QT00050281 
Hs_HMOX1 
 
CGT TTC TGC TCA ACA TCC AGC 
 
 
Qiagen/ 
QT00092645 
Table 3.1. The list of the primers used in this thesis. Primer names, their sequences, 
supplier company and their catalog numbers are given. 
 
3.1.8. Protein Molecular Weight Marker 
 
Protein molecular weight marker used in this study is listed in Appendix E. 
 
3.1.9. Equipments 
 
Equipments used in this study are listed in Appendix F. 
 
 
 
 
3.2. Methods 
 
 
3.2.1. Mammalian Cell Culture and Treatments 
 
The human promonocytic cell line U937 was obtained from Professor Giuseppe 
Poli, cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 2 
mM glutamine, 100 U/ml penicillin/streptomycin and maintained at 37 °C with 5% CO2 
in a humidified incubator. The cells were dispensed at 1×10
6 
/mL in culture plates 96-
well, 6-well, 12-well, 60 mm or 100 mm depending on the experiment and made 
quiescent through overnight incubation in serum-free medium; they were then placed in 
RPMI-1640 medium with 2% fetal bovine serum and treated with 27-OH  dissolved in 
ethanol. In some experiments, cells were pretreated (45min) with N-acetylcysteine 
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(NAC), an antioxidant compound, or with PD98059, a selective inhibitor of MEK1/2, or 
with diphenyleneiodonium chloride (DPI) , an inhibitor of nitric oxide synthase, or with 
LY294002, a selective inhibitor of PI3K. 
 
3.2.2. Cell death, viability and proliferation assays 
 
In order to detect cell viability or cell proliferation, exposure to 27-OH was 
determined by WST-1 (Cell Proliferation Reagent) following the manufacturer’s 
instruction. Briefly, U937 cells seeded in 96-well plates were treated as indicated and 10 
μl of WST-1 reagent was added to each well, after which the plates were incubated for 
4h at 37 °C. Absorbance was measured with a microtiter plate reader at a reference 
wavelength of 655nm and a test wavelength of 450 nm. Results were expressed as 
percentage of cell viability, proliferation versus controls, taken as 100%. Apoptotic cell 
death response was determined by an AnnexinV affinity assay. U937 cells seeded in 12-
well plates were treated as indicated, transferred to flow cytometry tubes, and harvested 
by centrifugation at 300g for 5min. The cells were then resuspended in 1ml of cold PBS 
and again centrifuged at 300g for 5min. After removal of supernatant, the cells were 
incubated in AnnexinV buffer (see Appendix D) containing 1% (v/v) AnnexinV (FITC) 
for 15 min in the dark. Cells were analyzed by FACS on FlowJo software. The rate of 
apoptosis was evaluated through 4,6-diamidino-2-phenylindole (DAPI) staining. To 
identify apoptotic nuclei, cells were fixed and permeabilized with 95% cold ethanol for 
5 min at room temperature, and then washed twice with 0.1 M PBS. Slides were then 
incubated for 15 min at room temperature in DAPI solution. After rinsing in PBS, cells 
were observed and photographed under a Zeiss Axiovert 200 M fluorescence 
microscope. 
 
3.2.3. Cleaved caspase 3 staining 
 
Cells were seeded in 12-well plates and subjected to 3% formaldehyde (w/v) 
fixation for 10 min. Fixed cells were incubated with Methanol  for 15 min at room 
temperature for permeabilization and washed with % 0.5 BSA (w/v) containing FACS 
incubation buffer (see Appendix D). Cells were incubated for 1 hour with 1:400 anti-
cleaved caspase 3 monoclonal antibody and then with 1:800 FITC-anti-rabbit secondary 
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antibody for 30 min. After two washes with PBS (pH: 7, 4), cells were subjected to 
FACS analysis on FlowJo software. 
 
3.2.4. Quantification of 27-OH in U937 cells by mass spectrometry 
 
Cells were incubated with 10 M 27-OH up to 72h. At different incubation 
times, cells were centrifuged, washed with PBS, and resuspended in 1ml NaCl 0.9%. 
The deuterium labeled 27-OH-d7 was added as internal standard and lipids were 
extracted with chloroform–methanol (2/1, v/v). The intracellular concentrations of the 
oxysterol were quantified by isotope dilution mass spectrometry essentially as 
previously described (Iuliano et al., 2003). The mass spectrometer was set to the 
selected ion monitoring mode; the ions used for analysis were as follows: [
2
H7] 27-OH 
463 m/z, 27-OH 456 m/z. Quantification of the oxysterol was made by the internal 
standard ratio method. 
 
3.2.5. Protein extraction and immunoblotting 
 
Cells were treated as indicated and harvested by centrifugation at 300g for 30 s. 
Following resuspension in 1 ml of ice-cold PBS and transfer to 1.5 ml microfuge tubes, 
cells were spun at 2640g for 30 s. The pellet was lysed by incubation for 30 min in 200 
μl of cold cell lysis buffer. After centrifugation at 2640g for 10 min, the supernatant 
containing the total protein extract was removed and stored at -80°C. For nuclear and 
cytoplasmic extracts, following treatments and cold centrifugation, cell pellets were 
resuspended in hypotonic T1 buffer (see Appendix D) and incubated on ice for 20 min. 
After the cold incubation, tubes were centrifuged at max speed for 1 minute and 
supernatants containing cytoplasmic proteins were stored at -80°C. Nuclear protein 
isolation was carried out by incubation for 20 min on ice in a cold saline T2 buffer (see 
Appendix D). After cold centrifugation at 13,000g for 20 min, supernatants containing 
nuclear proteins were removed and stored at -80°C. Proteins (30 μg) were mixed with 
loading buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol 
blue, 0.125 M Tris/HCl pH:6.8) and separated on 10-15% SDS–polyacrylamide gel 
electrophoresis (PAGE) and blotted onto polyvinylidene difluoride (PVDF) membranes. 
The membranes were blocked with 5% blocking reagent in PBS-Tween 20 and 
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incubated with appropriate primary and horseradish peroxidase (HRP)-conjugated 
secondary antibodies in 5% blocking reagent. After the required washes with PBS 1X-
Tween 20, proteins were finally analyzed using an enhanced chemiluminescence 
detection system and exposed to Hyperfilm-ECL. All critical immunoblotting 
experiments were repeated at least three times. 
 
3.2.6. Measurement of protein concentration 
 
Protein concentrations of protein extracts were determined by Bradford solution. 
Bovine serum albumin (BSA, stock solution: 1mg/ml) was used as the standard protein. 
To constitute a standard graph, starting with 5μg BSA/well in 96-well plates, BSA was 
1:1 diluted. Samples were diluted 1:100 with Bradford solution which were added to the 
wells. Absorbance was spectrophotometrically measured at 595nm by a microtiter plate 
reader with the first standard set as blank. Protein concentrations in the samples were 
then determined by extrapolating their absorbance values against the standard curve. 
For every new assay a new standard curve was plotted. 
 
3.2.7. RNA extraction and cDNA preparation  
 
Total RNA was extracted from cells using TRIzol reagent, following the 
manufacturer’s instructions. RNA was dissolved in RNase-free water with RNase 
inhibitors. The amount and purity (A260/A280 ratio) of the extracted RNA were assessed 
spectrophotometrically. cDNA was synthesized by reverse transcription from 2 g RNA 
with a commercial kit and random primers, following the manufacturer’s instructions. 
 
3.2.8. Real-time RT-PCR 
 
Singleplex real-time reverse transcription-polymerase chain reaction (RT-PCR) 
was performed on 30 ng of cDNA using TaqMan gene expression assay kits prepared 
for human NFE2L2 (Nrf2), HO-1, NQO-1 and -actin, and TaqMan Fast Universal 
PCR master mix, and analyzed by a 7500 Fast real-time PCR system. The 
oligonucleotide sequences are not revealed by the manufacturer because of proprietary 
interests. The cycling parameters were as follows: 20 s at 95 °C for AmpErase UNG 
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activation, 3 s at 95 °C for AmpliTaq Gold DNA polymerase activation, and 40 cycles 
of 3 s each at 95 °C (melting) and 30 s at 60 °C (annealing/extension). The fractional 
cycle number at which fluorescence passes the threshold in the amplification plot of 
fluorescence signal vs. cycle number was determined for each gene considered. The 
results were then normalized to the expression of -actin, as housekeeping gene. Target 
gene expression was quantified relatively with a mathematical method proposed by 
Livak & Schmittgen (Livak and Schmittgen, 2001). 
 
3.2.9. siRNA transfection 
 
Small interfering RNA (siRNA) was used for transient gene knockdown studies. 
The siRNAs used were NFE2L2 s9493 (Nrf2) and siRNA #1 for the negative control 
(scramble siRNA). Negative control corresponds to a siRNA with nonspecific sequence. 
Transfection of Nrf-2-specific and control siRNAs was performed following the 
manufacturer’s instructions. Briefly, 50 nM of siRNAs was mixed with 25 L of 
transfection reagent solution and left at room temperature for 10 min in RPMI medium 
with 1% fetal bovine serum and without antibiotics. After 24 h of reverse transfection, 
the cells (4104 500 L-1) were incubated with 27-OH for 24 h. For gene expression 
analysis, total RNA was isolated from the cells and used for quantitative RT-PCR as 
described above. The transfection efficiency, validated by quantitative RT-PCR, was 
approximately 87%. 
 
3.2.10. Measurement of intracellular reactive oxygen species 
 
The overproduction of reactive oxygen species (ROS), mainly superoxide anion 
(O2
-
), was detected by didihydroethidium (DHE) fluorescence staining. After treatment 
with 27-OH, in the presence or absence of selective inhibitors, the cells were washed 
and resuspended with RPMI-1640 medium (+2% fetal bovine serum) and incubated for 
30 min in the dark with 5 μM DHE at 37 °C. Fluorescence was immediately detected on 
glass base dishes by a laser scanning confocal microscope (planneofluar lens 40x/0.75) 
setting the exciting laser band to 543nm, and using a 560–615nm band  pass emission 
filter. All images were processed using LSM510 Image Examiner software. 
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3.2.11. Measurement of intracellular hydrogen peroxide  
 
 To measure hydrogen peroxide (H2O2) production, cell aliquots were lysed 
for cytosolic protein analysis in ice-cold buffer containing 20 mM Hepes, pH 7.9, 0.35 
M NaCl, 20% glycerol, 1% Igepal CA-630, 1 mM MgCl2, 0.5 mM EDTA, 0.1 mM 
EGTA, and protease inhibitors. Levels of H2O2 were determined in the cytosolic 
fractions by monitoring the HRP-dependent oxidation of acetylated ferrocytochrome c, 
as described by Zoccarato et al (Zoccarato et al., 1993). Ferrocytochrome c (0.8 ml of 
50 μM), HRP (2 μl of 40 μg/ml), and p-hydroxyphenylacetic acid (100 μl of 50μM) 
were added to 100 μl cytosolic samples. The oxidation of acetylated ferrocytochrome c 
was monitored spectrophotometrically at 550 minus 540 nm, after 1, 2, and 3 min of 
incubation, using an absorption coefficient of 19.9 mM
-1
 cm
-1
. 
 
3.2.12. Measurement of transmembrane mitochondrial potential 
 
5,50,6,60-Tetrachloro1,10,3,30-tetraethylbenzimidazolylcarbocyanine iodide 
(JC-1) is a cationic dye that exhibits membrane-potential-dependent accumulation in 
mitochondria as J-aggregates that, in depolarized mitochondria, are converted to JC-1 
monomers; this is indicated by the fluorescence emission shift from red to green. Before 
incubation with oxysterols and specific inhibitors, U937 cells were incubated for 10min 
with 10 mg/ml JC-1 in RPMI 1640 medium with 1% fetal bovine serum. After 
treatments, cells were observed through a LSM510 confocal laser microscopy system. 
The images were processed using LSM510 Image Examiner software. 
 
3.2.13. Statistical Analysis 
 
All the illustrated results represent one of at least three independent experiments 
with similar outcomes. All numerical data are presented as means ± standard deviation 
(SD). Statistical significance of the results was analyzed by the Student's t-tail test and 
*P<0.05, **P<0.01 and ***P<0.001 were considered statistically significant. 
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3.2.14. Densitometric analysis 
 
Densitometric values for immunoblotting results were calculated using Image J 
software. 
 
3.2.15. Illustrations 
 
All illustrations in all sections including “Introduction”, “Results”, “Discussion” 
and “Conclusion” were designed using Adobe Photoshop CS5 & CS6, IrfanView and 
MS Office 2007 and 2010 softwares. 
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4. RESULTS 
 
 
 
 
4.1. Effect of 27-OH treatment on cell viability and cell death in U937 
promonocytic cells 
 
4.1.1. Dose-dependent pro-apoptotic effect of 27-OH 
 
In order to determine the pro-apoptotic effect of 27-OH, aliquots of U937 cells 
were incubated with different final concentrations (10, 50 and 100 µM) of 27-OH for up 
to 72 h. Cell death was then assessed by the Annexin V test and present results show 
that 27-OH-induced apoptosis in U937 promonocytic cells depending on its final 
concentration (Fig. 4.1).  In particular, concentrations above 50 µM of 27-OH doubled 
the number of Annexin V-positive cells present versus the control after 24 h cell 
treatment indicating the cells undergoing cell death, while at low concentrations of 27-
OH (10 µM), significant induction of apoptosis only occurred after 72 h. 
 
To investigate the type of cell death in high concentrations of 27-OH treated 
U937 cells, after 24 h incubation with 10 and 100 µM, cells were fixed, permeabilized 
and labeled with cleaved caspase 3 monoclonal antibody and evaluated by FACS 
analysis (Figure 4.2). While at a final concentration of 100 µM showed active caspase 3 
positive cells about 30%, cells treated with low concentration (10 µM) did not show a 
significant change in caspase 3 cleavage after 27-OH treatment. These results indicate 
that cell death induced by high concentration of 27-OH is mainly apoptotic The 
anticancer drug cisplatin (30 µM) was used a positive control for this experiment and 
showed active caspase 3 positive cells as expected.  
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Figure 4.1. The pro-apoptotic effect of 27-hydroxycholesterol (27-OH) is dose 
dependent. Different kinetics of 27-OH-induced apoptosis in U937 cells was determined 
by flow cytometry. U937 cells were treated with increasing concentrations of 27-OH 
(10, 50 and 100 µM) for 24, 48, and 72h, stained with FITC– AnnexinV and subjected 
to FACS analysis. Untreated cells (Control) were used as controls. Relevant histograms 
represent the mean values ±SD of all four independent experiments; *P<0.01, 
**P<0.005, and ***P<0.001 vs control at each time point. 
 
 
Figure 4.2. High micromolar concentration of 27-hydroxycholesterol (27-OH) induces 
apoptosis.  U937 cells were treated with 27-OH (10 µM and 100 µM) for 24 h or 
cisplatin 30 µM for positive control and then incubated with a specific monoclonal 
antibody against cleaved caspase 3. Following required washes, cells were subjected to 
FITC anti-rabbit antibody incubation. Stained cells were then analyzed by flow 
cytometry.  Untreated cells (Control) were used as controls. Relevant histograms 
represent the mean values ±SD of all three independent experiments; ***P<0.001 vs. 
control at each time point. 
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4.1.2. Pro-apoptotic effect of low micromolar concentration of 27-OH 
 
Physiological level of oxysterols in plasma is very low and it has been shown 
that the concentration of 27-OH in human serum is about 117±35 ng/ml (Honda et al., 
2009). Previous studies have shown that concentrations of oxysterols above 50 μg/ml 
could be pro-apoptotic (Trevisi et al., 2009). Thereby, we have used the lowest 
oxysterol concentration, i.e., 10 µM of 27-OH in further experiments for the evaluation 
of molecular and cellular mechanisms of survival effects of oxysterol. 
 
Focusing on the low concentration of 27-OH (10 µM), cell viability and 
proliferation was measured in terms of WST-1 tetrazolium salt reduction by cellular 
dehydrogenases (Fig. 4.3. A). WST-1 assay which was performed for the interval 
considered (0–72h), showed that 10 µM 27-OH caused a slight though significant 
reduction of cell viability and proliferation at 72 h. However, it induced a slight increase 
in cell proliferation after 6-12 h treatment of 27-OH suggesting that a survival 
adaptation response was induced. 
 
In addition to WST-1 assay, we also performed an Annexin V staining to 
confirm assay results and also to determine a time course of its pro-apoptotic effect in 
response to low concentration of 27-OH (Fig. 4.3 B). U937 cells were treated with 27-
OH up to 7 days and time course of pro-apoptotic effect was evaluated by FACS 
analysis. Under the experimental conditions applied here, the number of apoptotic cells 
was about 20% of the total after 3 days, 40% after 5 days, and about 60% after 7 days of 
treatment. A significant induction of apoptosis was obtained after long term treatment of 
low concentration of 27-OH. 
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Figure 4.3. The pro-apoptotic effect of 27-hydroxycholesterol (27-OH) is time 
dependent. (A) Effect of 27-OH (10 µM) on U937 cell viability. Viability of U937 cells 
was analyzed by the WST-1 assay, following treatment with 10 µM 27-OH for times 
between 6 and 72 h. Untreated cells (Control) were taken as controls. Average 
absorption values versus untreated cells are displayed after multiplication by 100. Assay 
and results represent the mean values ±SD of all three independent experiments with six 
repeats; *P<0.05 vs. control. (B) Time course of the pro-apoptotic effect of a low 
micromolar amount (10 µM) of 27-OH. Cells were treated for 1 to 7 days with 27-OH at 
a final concentration of 10 µM and cell death was analyzed by flow cytometry. 
Untreated cells (Control) were taken as controls. Histograms represent the mean values 
±SD of all four independent experiments; *P<0.01 and **P<0.001 vs. control at each 
time point. 
 
 
 
 
A 
B 
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4.2. Determination of 27-OH actual concentrations in 27-OH treated U937 
promonocytic cells 
 
 As discussed above, the physiological level of oxysterols in plasma is very low. 
Since 10 µM dose is much higher than given the physiological concentration, we 
measured 27-OH concentrations in 27-OH treated U937 promonocytic cells to show 
that the levels do not exceed the pathophysiological range. Thus, in order to quantify the 
27-OH amount actually present overtime within promonocytic cells, U937 cells were 
incubated with a single dose of 10 µM 27-OH up to 72 h. After different incubation 
times (5min-72h), cell aliquots were taken from the same cell suspension and 27-OH 
intracellular amount was quantified by mass spectrometry as described under Materials 
and Methods. As shown in Fig.4.4, from the very beginning (1.5 h) the amount of 27-
OH ranged between 18 and 26% of the total oxysterol amount added to the cells, 
showing a steady concentration over the experimental time (up to 72 h) with non 
significant and minor variations. 
 
 
 
Figure 4.4. Measurement of 27-hydroxycholesterol (27-OH) amount within U937 cells. 
Cells were treated up to 72 h with a single dose of 10 µM 27-OH and the oxysterol 
concentrations were measured by mass spectrometry. Histograms represent the 
percentage of 27-OH present in the cells compared to the total oxysterol administered 
(100%) at each time point. 
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4.3. 27-OH induced modulation of ERK1/2 and PI3K/Akt survival pathways 
 
4.3.1. Low micromolar concentration of 27-OH produces stimulation of ERK1/2 
and Akt phosphorylation 
 
After determination oxysterol actual amount in cells and selection final 
concentration of 27-OH, the molecular mechanism of the survival signal in response to 
low concentration of 27-OH was questioned. In order to get more detailed insight on 
molecular mechanism at the signal transduction level, a possible involvement of two 
well-known cell survival signals, ERK1/2 and Akt was investigated. Since the well-
known apoptotic effect of 27-OH was actually delayed by almost 3 days when U937 
cells were incubated in the presence of a 10 µM concentration, the possible prevalence 
of survival signals over death signals during this early time interval (up to 72 h) was 
investigated. As reported in Fig.4.5, low micromolar concentration of 27-OH produces a 
transient stimulation of ERK1/2 and Akt survival pathways. The results demonstrated 
that a significant increase of ERK1/2 and Akt (Thr308) phosphorylation was observed 
in U937 cells treated with 10 µM 27-OH. Moreover, this up-regulation marked at 
maximum between 6 and 24 h incubation with regard to ERK, and between 6 and 48 h 
incubation in the case of Akt.  
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Figure 4.5. Phosphorylation of ERK1/2 and Akt induced by low micromolar 
concentration of 27-hydroxycholesterol (27-OH). U937 cells were treated with 10 μM 
27-OH for 3 to 72 h. Untreated cells (Control) were taken as controls. Levels of 
phosphorylated ERK1/2 and phosphorylated Akt proteins were analyzed by Western 
blotting. Αctin was used as loading control. One blot representative of three 
experiments is shown for each protein. Histograms represent the mean values ±SD of all 
three independent experiments; densitometric measurements were normalized against 
the corresponding actin levels and expressed as percentage of control values; *P<0.01, 
**P<0.005, and ***P<0.001 vs. control. 
 
 4.3.2. Effect of high micromolar concentration of 27-OH on ERK1/2 and Akt 
phosphorylation 
 
 Although, low molecular concentration of 27-OH may induce survival 
response including ERK1/2  and Akt signaling pathways, it raised the question whether 
if pro-apoptotic, high concentration of the oxysterol inhibited these survival pathways 
or had any negative effect on the given response. Thus, immunoblotting experiments 
were performed up to 72h  with U937 cells treated with 100 µM 27-OH. As shown in 
Fig.4.6, high micromolar concentration of 27-OH does not induce any survival response 
including ERK1/2 and Akt signaling pathways. A significant down-regulation was 
observed in U937 cells which occurred at 6h and between 48-72 h incubation with 
regard to ERK, and between 24 and 48 h incubation in the case of Akt. According to 
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these results, it can be suggested that 27-OH induced survival response in promonocytic 
cells is treated concentration and time specific.  
 
 
 
Figure 4.6. High micromolar concentration of 27-hydroxycholesterol (27-OH) does not 
induce ERK1/2 and Akt phosphorylation. U937 cells were treated with 100 μM 27-OH 
for 3 to 72 h. Untreated cells (Control) were taken as controls. Levels of phosphorylated 
ERK1/2 and phosphorylated Akt proteins were analyzed by Western blotting. Αctin was 
used as loading control. One blot representative of three experiments is shown for each 
protein. Histograms represent the mean values ±SD of all three independent 
experiments; densitometric measurements were normalized against the corresponding 
actin levels and expressed as percentage of control values; *P<0.01 vs. control. 
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4.4. Expression of Bcl-2 family proteins in response to low micromolar 
concentration of 27-OH   
 
After signal transduction level of the survival response mechanism was 
elucidated, the role of B-cell lymphoma (Bcl)-2 family proteins was investigated, which 
are the important apoptosis regulators and placed at the helm of the execution phase of 
apoptosis. For this purpose, to determine the expression pattern of anti and pro-
apoptotic members of Bcl-2 family, U937 cells were treated with low concentration of 
27-OH then total cell lysates were subjected to immunoblotting using specific 
antibodies. 
 
4.4.1. Increased phosphorylation of Bad at Ser75 and Ser99, in U937 cells 
challenged with a low micromolar concentration of 27-OH 
 
Based on the finding that activation of the PI3K/Akt signaling pathway 
culminates in phosphorylation of the Bcl-2 family member pro-apoptotic Bad protein, 
and it thus promotes cell survival through inhibiting Bad’s pro-apoptotic effect  (Datta 
et al., 1997), phosphorylation of Bad protein was examined by immunoblotting, in 
U937 cells treated with 10 μM 27-OH up to 72 h. As illustrated in Fig.4.7, Bad was 
phosphorylated at the level of Ser75 at some point between 3 and 72 h cell incubation, 
likely in connection with MEK/ERK phosphorylation. The maximum increase in Bad 
phosphorylation in response to 27-OH treatment was observed by 12 h. Moreover, Bad 
phosphorylation was also observed at its Ser99 residues at some point between 3 and 48 
h cell incubation which reached a maximum at 12 h, likely depending on 27-OH 
induced Akt phosphorylation.  
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Figure 4.7. Phosphorylation of pro-apoptotic Bad protein induced by 27-
hydroxycholesterol (27-OH). U937 cells were treated with 10 μM 27-OH for 3 to 72 h. 
Untreated cells (Control) were taken as controls. Levels of phosphorylated Bad (Ser 75 
and Ser 99) proteins were analyzed by Western blotting. Αctin was used as loading 
control. One blot representative of three experiments is shown for each protein. 
Histograms represent the mean values ±SD of all three independent experiments; 
densitometric measurements were normalized against the corresponding actin levels and 
expressed as percentage of control values; *P<0.01, **P<0.005, and ***P<0.001 vs. 
control. 
 
4.4.2. Bim and Bcl-xl proteins are not involved in survival response induced by low 
micromolar concentration of 27-OH 
 
 In addition to Bad protein, to elucidate the expression pattern of Bcl-2 family 
proteins in detail, the expression of two important apoptosis/survival regulators, pro-
apoptotic Bim and anti-apoptotic Bcl-xl proteins was analyzed by immunoblotting. For 
this purpose, U937 cells were treated with 10 μM 27-OH up to 48 h and then total cell 
lysates were subjected to immunoblotting using antibodies specific for Bcl-xl and Bim. 
As shown in Fig.4.8, while Bcl-xl expression very slightly increased at 12 h in response 
to low concentration of 27-OH, Bim expression did not indicate a significance change.  
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Figure 4.8. Modulation of anti-apoptotic Bcl-xl and pro-apoptotic Bim proteins by 27-
hydroxycholesterol (27-OH). U937 cells were treated with 10 μM 27-OH for 3 to 48 h. 
Untreated cells (Control) were taken as controls. Levels of Bcl-xl and Bim proteins 
were analyzed by Western blotting. Αctin was used as loading control. One blot 
representative of three experiments is shown for each protein. Histograms represent the 
mean values ±SD of all three independent experiments. 
 
4.5. Effect of MEK/ERK and PI3K/Akt signaling pathways inhibition on the pro-
apoptotic effect of 27-OH 
 
In order to determine the noncytotoxic concentrations of two metabolic 
inhibitors, namely the MEK/ERK inhibitor, PD98059 and the PI3K/Akt inhibitor, 
LY294002, FACS analysis was utilized. Therefore, U937 cells were treated with 
different concentrations of inhibitors and incubated for 24 h, and then cells were 
subjected to FITC–AnnexinV staining to analyze the cell death by flow cytometry. The 
FACS analysis results showed that 10, 20, 40 μM final concentrations for PD98059 
(Fig.4.9 A) and 10 and 25 μM final concentrations for LY294002 (Fig.4.9 B) are 
noncytotoxic for U937 promonocytic cells. Depending on the results obtained and 
previously published papers, 40 μM PD98059 and 25 μM LY294002 were used for 
further molecular experiments. 
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To investigate the involvement of ERK and Akt signaling pathways in low 
concentration of 27-OH induced survival response, U937 cell suspensions preincubated 
(45 min) with either ERK or Akt inhibitors, PD98059 and LY294002 respectively. The 
number of Annexin V positive cells was measured by FACS analysis and the percentage 
of apoptotic cells was already about 20%, after 24 h challenge with 10 μM 27-OH (Fig. 
4.9 C) which is approximately the percentage of apoptotic cells induced by this low 
concentration of 27-OH when cell incubation was continued to 72 h in the absence of 
the ERK/ Akt inhibitors. In particular, the importance of ERK and Akt-dependent 
survival signaling inhibition on cell survival was of course more evident after 48 and 72 
h oxysterol incubation of U937 cells; the percentage of apoptosis was measured as 30% 
after 48 h and about 40% after 72 h treatment of the oxysterol. These results support 
that prevention of ERK-Akt-dependent survival signaling anticipated the pro-apoptotic 
effect of the low micromolar concentration of the oxysterol. 
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Figure 4.9. Inhibition of MEK/ERK and PI3K/Akt signaling pathways anticipates the 
apoptotic effect of 10 μM 27-OH. Untreated cells were taken as controls. Cells were 
treated with indicated concentrations of inhibitors for 24 h. Cytotoxicity of inhibitors 
(A) PD98059, a selective MEK1/2 inhibitor, and (B) LY294002, a selective PI3K 
inhibitor was determined by flow cytometry. (C) U937 cells were either treated with 27-
OH (10 μM) alone or preincubated with PD98059 (40 μM) or LY294002 (25 μM) 45 
min before 27-OH treatment. FACS analysis was performed by harvesting and FITC–
AnnexinV staining the cells at 24, 48, and 72 h, to analyze the effect of inhibitors on 
cell death response. Histograms represent the mean values ±SD of all four independent 
experiments; *P<0.01 and **P<0.001 vs. control at each time point; #P<0.005 and 
##P<0.001 vs. 27-OH at each time point. 
C 
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4.6. Effect of MEK/ERK and PI3K/Akt signaling pathways inhibition on the 27-
OH induced Bad phosphorylation 
 
To examine the dependence of Bad phosphorylation and of the consequent loss 
of its pro-apoptotic potential, on the activation of either ERK (Bad phosphorylation at 
Ser75) or Akt (Bad phosphorylation at Ser99) a series of immunoblotting experiments 
were performed employing two metabolic inhibitors, PD98059 and LY294002. 
Therefore, U937 cell aliquots were pretreated (45 min) with either 40 μM PD98059 or 
25 μM LY294002. The results showed that MEK/ERK inhibitor PD98059 dramatically 
reduced ERK1/2 phosphorylation after 6 and 12 h treatment with 10 μM 27-OH (Fig. 
4.10 A). Moreover, it significantly prevented Bad phosphorylation at Ser75. As 
expected, cell pretreatment with PI3K/Akt inhibitor LY294002 fully prevented Akt 
phosphorylation and Bad phosphorylation at Ser99 after 6 and 12 h treatment with 10 
μM of the oxysterol (Fig. 4.10 B). These results confirmed the dependence of Bad 
phosphorylation to ERK-Akt signaling pathways that results in marked anticipation of 
the pro-apoptotic effect of 27-OH. 
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Figure 4.10. Erk- and Akt-dependent Bad phosphorylation: effect of selective 
inhibitors. U937 cells were either treated with 27-OH (10 μM) alone (6 and 12 h) or 
preincubated with PD98059 (40 μM) or LY294002 (25 μM) 45 min before 27-OH 
treatment. Untreated cells were taken as controls. (A) Levels of phosphorylated and 
nonphosphorylated ERK1/2, phosphorylated Bad (Ser75), and (B) phosphorylated Akt 
and phosphorylated Bad (Ser99) proteins were analyzed by Western blotting. Αctin was 
used as loading control. One blot representative of three experiments is shown for each 
protein. 
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4.7. Determination of intracellular ROS levels in U937 cells treated with 27-OH  
 
The pro-oxidant effect of low dose of 27-OH in U937 promonocytic cells was 
determined with the fluorescent probe DHE as shown in Fig.4.11. Challenging U937 
cells with a single 10 M dose of 27-OH for a time interval between 30min-96h, 
confirmed the pro-oxidant effect of this oxysterol in which a biphasic increase of ROS 
steady-state levels was observed. As shown in microscopy results, in DHE-stained cells 
with red fluorescent, intracellular ROS showed a peculiar trend; a marked increase of 
ROS levels was evident until 4–5 h of cell treatment. However, ROS intracellular levels 
disappeared between 6 and 24/48 h of cell treatment, and interestingly reappeared at 
longer incubation times such as 72 and 96 h. This peculiar trend suggested that ROS 
disappearance correlates with maximum phosphorylation times (6-12 h) of ERK and 
Akt signaling pathways. Thus, the first oxidative burst was demonstrated after 30 min- 
3h incubation, to be responsible for the transient up- regulation of ERK1/2 and Akt 
phosphorylation. 
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Figure 4.11. Pro-oxidant effect of low micromolar concentration of 27-
hydroxycholesterol (27-OH). Intracellular generation of ROS was run with 
dihydroethidium (DHE) in U937 cells incubated with the oxysterol for 1 to 72 h. 
Untreated cells (Control) were taken as controls. 
To confirm DHE staining results for intracellular ROS generation, another 
technique was also used. Therefore, U937 promonocytic cells treated with a single dose 
of 27-OH (10 M) and then incubated up to 72 h at 37°C, the pro-oxidant effect of the 
oxysterol was confirmed by monitoring H2O2 production. As shown in Fig. 4.12, a 
significant increase in ROS intracellular levels was evident until 6 h incubation; 
however it disappeared at longer incubation times, i.e. between 12 and 72 h. These 
results confirmed the remarkable but transient pro-oxidant effect of the low dose of the 
oxysterol. As shown by DHE staining previously, in the time frame corresponding to 
the up-regulation of phosphorylation of ERK and PI3K/Akt induced by 27-OH, i.e. 
between 6 and 24 h after cell treatment, ROS generation resulted to be quenched. This 
finding suggested the ability of ERK and Akt signaling pathways to modulate the 
steady-state of cellular ROS. 
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Figure 4.12. Effect of 27-hydroxycholesterol (27-OH) on H2O2 production. U937 cells 
were incubated with 10 M 27-OH for 1 to 72 h. H2O2 production was measured 
spectrophotometrically. Histograms represent the mean values ±SD of all three 
independent experiments. **p<0.005 and ***p<0.001 vs. control group. 
 
4.7.1. Effect of high micromolar concentration of 27-OH on ROS generation 
 
 To observe any difference between low, 10 M and high, 100 M 
concentrations of 27-OH on ROS generation, U937 cells treated with high 
concentrations of 27-OH and incubated between 1 and 24 h. The pro-oxidant effect of 
100 M 27-OH was determined with the fluorescent probe DHE as shown in Fig.4.13. 
DHE red fluorescence increased up to 24 h compared to untreated control cells and a 
lasting ROS production was observed while the marked quenching of ROS generation 
induced by low concentration of oxysterol was not any more observed in U937 cells. 
Moreover, the morphological change such as cell shrinkage was observed in U937 cells 
challenged with 27-OH for 24 h that confirmed the apoptotic effect of high 
concentration of oxysterol’s. 
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Figure 4.13. Pro-oxidant effect of 100 M 27-Hydroxycholesterol (27-OH). 
Intracellular ROS generation was measured by dihydroethidium (DHE) florescence 
staining in U937 cells incubated with the oxysterol from 1-24 h. Untreated cells 
(Control) were taken as controls. 
 
4.8. Dependence of 27-OH induced ERK and Akt phosphorylation on the ROS 
increase 
 
In order to determine the noncytotoxic concentrations of antioxidant NAC, 
FACS analysis was utilized. Therefore, U937 cells were treated with different 
concentrations of NAC and incubated for 24 h, and then cells were subjected to FITC–
AnnexinV staining to analyze the cell death by flow cytometry. The FACS analysis 
results showed that 0.1, 1 and 10 mM final concentrations for NAC (Fig.4.14 A) are 
noncytotoxic for U937 promonocytic cells. Depending on the results obtained and 
previously published studies, 100 μM NAC was used for further experiments. 
 
 To confirm antioxidant potential of NAC in U937 cells, DHE staining was 
performed using NAC, at a noncytotoxic concentration (100 M). Challenging U937 
cells with a single 10 M dose of 27-OH for 3h showed that cell pretreatment with 
NAC (45 min) able to impede the intracellular rise of ROS (Fig. 4.14 B).  
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After determining the regulatory role of NAC on the pro-oxidant effect of 27-
OH, immunoblotting experiments were performed to examine whether NAC 
pretreatment has a similar effect on ERK and Akt phosphorylation. As shown in Fig. 
4.14 C, challenging cells with NAC fully prevented 27-OH-dependent up-regulation of 
both ERK1/2 and Akt phosphorylation at 3 and 6h. Based on these findings, it can be 
suggested that 27-OH induced ERK1/2 and Akt phosphorylation is ROS-dependent in 
U937 promonocytic cells. 
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Figure 4.14. Modulation of 27-hydroxycholesterol’s (27-OH) pro-oxidant effect by N-
acetylcysteine (NAC). (A) Cytotoxicity of NAC was determined by flow cytometry. 
Cells were treated with indicated concentrations of NAC for 24 h, stained with FITC– 
AnnexinV and subjected to FACS analysis. (B) Protection exerted by NAC 
pretreatment on ROS generation. U937cells were treated for 3h with 10 M 27-OH. 
Untreated cells (Control) were taken as controls. Other cells were preincubated with 100 
M NAC for 1h and then treated with 27-OH for 3h. (C) Effect of NAC pretreatment on 
27-OH-dependent ERK and Akt phosphorylation. Untreated cells were taken as 
controls. Other cells were preincubated (1h) with 100 M NAC and then treated for 3 
and 6h with 27-OH at a final concentration of 10 M. The levels of pERK1/2 and pAkt 
were analyzed by Western blotting. One blot representative of three experiments is 
shown for each protein. 
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4.9. Effect of MEK/ERK and PI3K/Akt signaling pathways inhibition on 
intracellular ROS levels 
 
Given the observation that the time interval of the transient quenching of 27-
OH’s pro-oxidant effect corresponded to the transient prevalence of ERK- and Akt-
dependent survival signaling, it was decided to examine the potential interference of 
such survival signals with ROS generation. For this purpose, cells were pretreated with 
either PD98059 or LY294002 and subjected to DHE staining to determine intracellular 
ROS levels. As shown in Fig. 4.15, the inhibition of ERK1/2 and Akt phosphorylation, 
by cell pretreatment with selective inhibitors, indeed abolished the transient 
disappearance of 27-OH’s pro-oxidant effect. A high level of intracellular ROS was also 
observed after 12 h challenge with 10 M 27-OH, provided that cells were pretreated 
with MEK/ERK or PI3K/Akt inhibitors while cells were treated only with PD98059 or 
LY294002 did not induce any pro-oxidant effect.  In addition, the sustained elevation of 
the ROS steady state was proven both by DHE staining and by H2O2 measurement. Data 
shown that pretreated cells with MEK/ERK or PI3K/Akt inhibitors significantly 
increased ROS production at 12 h incubation with low micromolar concentration of 27-
OH. 
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Figure 4.15. Modulation of 27-hydroxycholesterol’s (27-OH) pro-oxidant effect by 
pERK1/2 and pAkt selective inhibitors. U937 cells were incubated with l0 M 27-OH 
for 12 h. Untreated cells (Control) were taken as controls. Some cells were preincubated 
with PD98059 (40 M) or LY294002 (25 M) for 45 min and then treated with 27-OH 
for 12 h. Other cells were treated only with PD98059 or LY294002 as internal controls. 
The overproduction of ROS was detected by dihydroethidium (DHE) fluorescence 
staining, while H2O2 production was measured spectrophotometrically. Histograms 
represent the mean values ±SD of three experiments; *P<0.05 vs. 27-OH. 
 
4.10. Determination cellular source of ROS increased in 27-OH treated U937 cells 
 
Previous studies pointing to oxysterols’ ability to impair mitochondrial 
membrane potential (Δψm) and upregulate Nox-2, thus increasing the intracellular ROS 
production (Biasi et al., 2009; Gargiulo et al., 2011). According to these findings, it was 
decided to check derangement of Δψm and activation of Nox-2 in 27-OH-treated cells, 
after 12 h incubation, in the presence or absence of pharmacological inhibitors PD98059 
and LY294002. As reported in Fig. 4.15, 12 h incubation of U937 cells with 27-OH 
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alone did not cause any significant ROS increase versus control cells, unless the 
contemporary upregulation of ERK and Akt phosphorylation was inhibited. In addition 
to this,  cells were subjected to JC-1 staining which is a cationic dye that only enters 
into mitochondria with high Δψm, when its color changes from green to red, displayed 
an intense red fluorescence only in 27-OH-treated and control cells. However, it showed 
diffuse green fluorescence, indicating Δψm depression, when cells were challenged with 
27-OH in the presence of selective inhibitors, PD98059 and LY294002 (Fig. 4.16 A). 
Moreover, the expression of Nox-2 which is an additional source of ROS was analyzed 
by immunoblotting in 27-OH-treated U937 cells. According to results, Nox-2 activation 
was observed by a significant increase of membrane translocation of its component p47 
phox
 after 12 h incubation with 27-OH, only when MEK/ERK and PI3K/Akt survival 
signaling was inhibited by pharmacological inhibitors (Fig. 4.16 B).  
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Figure 4.16. Both mitochondrial depolarization and Nox-2 activity contribute to the 
pro-oxidant effect of 27-hydroxycholesterol (27-OH). U937 cells were treated for 12 h 
with l0 M 27-OH. Untreated cells (Control) were taken as controls. Other cells were 
preincubated with PD98059 (40 M) or LY294002 (25 M) for 45 min and then treated 
with 27-OH for 12h. (A) The transmembrane mitochondrial potential was detected by 
JC-1 staining, and (B) Nox-2 activation by Western blotting. One blot representative of 
three experiments is shown for each protein. Histograms represent the mean values ±SD 
of all three independent experiments; densitometric measurements were normalized 
against the corresponding actin levels and expressed as percentage of control values; 
***P<0.001 vs. control; ###P<0.001 vs. 27-OH. 
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4.11. Nrf2 pathway in response to 27-OH in U937 promonocytic cells 
 
With regard to the quenching of ROS intracellular levels by ERK and Akt 
survival signaling induction, of the pro-oxidant effect exerted in 27-OH challenged 
promonocytic cells, one likely explanation for this effect is the induction of antioxidant 
defense systems. While activation of these survival signaling pathways has repeatedly 
been demonstrated to induce Nrf2 and its antioxidant response (Kim et al., 2008; 
Papaiahgari et al., 2006; Wang et al., 2012, 2011), it was decided to investigate the 
effect of 27-OH treatment on Nrf2 pathway. 
 
4.11.1. Induction of Nrf2 expression, total cellular levels and nuclear translocation 
by low micromolar concentration of 27-OH 
 
To examine the induction of Nrf2 gene expression, cells were treated with low 
concentration of 27-OH for 1 and 3 h and mRNA levels were analyzed by RT-PCR. As 
reported in Fig. 4.17 A, a significant up-regulation of Nrf2 mRNA was detectable in 
U937 cells since the first few hours after addition of 10 M 27-OH to the incubation 
medium. In particular, after 3 h incubation with 27-OH, Nrf2 mRNA level was 
maximum and almost 2 fold induced. In order to elaborate Nrf2 antioxidant response 
induction, cells were challenged with 10 M 27-OH and total proteins were analyzed by 
immunoblotting (Fig. 4.17. B). In consistent with gene expression results, a net increase 
of Nrf2 total cellular levels was observed between 1 and 3 h in U937 cells. The 
transcription activity of Nrf2 mainly depends on nuclear shuttling in response to a 
stimulus. Thus, to investigate the localization of the transcription factor, cytoplasmic 
and nuclear protein fractions were obtained separately at 1 and 3 h and evaluated by 
Western blotting. Immunoblotting results demonstrated a marked stimulation of Nrf2 
nuclear translocation already after 1 h cell challenge with the low concentration of 27-
OH (Fig. 4.17. C). On the other hand, Nrf2 activation by 27-OH appeared to be 
transient, whereas after 3 h challenge, the nuclear level of the transcription factor in the 
oxysterol treated cells showed a decreasing trend. 
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Figure 4.17. 27-hydroxycholesterol (27-OH) induces gene expression, synthesis and 
nuclear translocation of Nrf2 in U937 cells. (A) Effect of 27-OH on the expression of 
Nrf2. Gene expression was quantified by real-time RT-PCR in U937 cells treated for 1 
and 3 h with 10 M 27-OH. Untreated cells were used as controls. Data, normalized to 
actin, are expressed as mean values ± S.D. of three different experiments. ***P < 0.001, 
and **P < 0.005 vs. control group. (B) Nrf2 protein level in U937 cells treated with 10 
μM 27-OH for 1 and 3 h was analyzed by Western blotting. Untreated cells (c) were 
taken as controls. Αctin was used as loading control. (C) Nrf2 expression in nuclear and 
cytoplasmic lysates was determined by Western blotting. Untreated cells (c) were taken 
as controls. Lamin A/C and actin were used as loading controls. One blot representative 
of three experiments is shown. Histograms represent the mean values ± S.D. of all three 
independent experiments; densitometric measurements were normalized against the 
corresponding actin levels and expressed as percentage of control values; *P<0.05, 
**P<0.01 and ***P<0.001 vs. control group. 
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4.11.2. High micromolar concentration of 27-OH does not induce Nrf2 total 
cellular levels and nuclear translocation  
 
 To examine whether Nrf2 antioxidant response induction is oxysterol’ 
concentration dependent, induction of Nrf2 pathway was evaluated in cells challenged 
with high concentration of 27-OH.  U937 cells treated with 100 M 27-OH for 1 and 3h 
and total cell lysates were analyzed by immunoblotting (Fig. 4.18 A). Results clearly 
showed that Nrf2 total cellular levels did not changed significantly compared to 
untreated control after oxysterol treatment. In order to determine the effect of high dose 
treatment on Nrf2 nuclear localization, Western blotting experiments was performed to 
evaluate this transcription factor levels in nuclear and cytoplasmic fractions. As shown 
in Fig. 4.18 B, 100 M 27-OH treatment did not significantly changed the localization 
of Nrf2 in U937 cells. After 1 and 3 h incubation with the oxysterol, nor cytoplasmic 
neither nuclear levels of transcription factor did not changed compared to untreated 
control. It was apparent that induction of Nrf2 antioxidant response was modulated only 
by low concentration of 27-OH in promonocytic cells. 
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Figure 4.18. Nrf2 synthesis and nuclear translocation not induced by high micromolar 
concentration of 27-hydroxycholesterol (27-OH).  (A) Nrf2 protein level in U937 cells 
treated with 100 μM 27-OH for 1 and 3 h was analyzed by Western blotting. Untreated 
cells (c) were taken as controls. Αctin was used as loading control. (B) Nrf2 expression 
in nuclear and cytoplasmic lysates was determined by Western blotting. Untreated cells 
(c) were taken as controls. Lamin A/C and actin were used as loading controls. One blot 
representative of three experiments is shown. Histograms represent the mean values ± 
S.D. of all three independent experiments; densitometric measurements were 
normalized against the corresponding actin levels and expressed as percentage of 
control values. 
A 
B 
75 
 
4.12. HO-1 and NQO-1 induction by 27-OH in U937 promonocytic cells 
 
It has been clearly demonstrated that Nrf2 plays a central role in controlling the 
expression of detoxyfying genes such as HO-1 and NQO-1 whose protein products are 
involved in the regulation of oxidative imbalance (Nguyen et al., 2009).  For the 
purpose of demonstrating HO-1 and NQO-1 induction by 27-OH in promonocytic 
human cells, HO-1 and NQO-1 mRNA and protein levels were measured, following 
incubation with the oxysterol at the concentration of 10 μM in U937 cells. The effect of 
27-OH on HO-1 and NQO-1 mRNA expression was checked by quantitative RT-PCR. 
As reported in Fig. 4.19 A, real-time RT-PCR results showed a significant upregulation 
of the expression of both antioxidant genes. In particular, HO-1 gene was increased 
after 3 h oxysterol treatment and the maximum increase was observed by 6 h, but it 
decreased thereafter. However, NQO-1 gene was rapidly increased with a maximal 
response after 3 h treatment and then with declining trend mRNA level returned to the 
basal value after 24 h treatment of the oxysterol. Furthermore, a net increase of both 
HO-1 and NQO-1 protein levels in U937 cells treated with low concentration of 27-OH 
was clearly presented by immunoblotting (Fig. 4.19 B). As demonstrated in Fig. 4.19 B, 
27-OH increased HO-1 protein level between 1 and 72 h treatment with a maximal 
response at 12 h, thereafter protein level slightly decreased up to 72 h. With regard to 
NQO-1, in U937 cell suspension challenged with 10 µM 27-OH a marked up-regulation 
was observed for its protein levels between 3 and 72 h treatment (Fig. 4.19 B). 
Statistical analysis of all data obtained for 1-72 h time interval demonstrated that HO-1 
and NQO-1 synthesis was significantly increased in 27-OH-treated cells compared with 
untreated control cells. 
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Figure 4.19. Effect of 27-hydroxycholesterol (27-OH) on HO-1 and NQO-1 expression 
and protein levels. (A) Expression of HO-1 and NQO-1 genes was quantified by real-
time RT-PCR in U937 cells treated up to 24 h with 10 μM 27-OH. Data, normalized to 
actin, are expressed as mean values ± S.D. of four different experiments. (B) Protein 
levels of HO-1 and NQO-1 in U937 cells treated with 10 μM 27-OH for 1 to 72 h, were 
analyzed by Western blotting. Untreated cells (c) were taken as controls. Αctin was used 
as loading control. One blot representative of three experiments is shown for each 
protein. Histograms represent the mean values ± S.D. of all three independent 
experiments; densitometric measurements were normalized against the corresponding 
actin levels and expressed as percentage of control values; *p < 0.05 and **p < 0.01 and 
***p < 0.001 vs. control group. 
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4.13. Effect of 27-OH induced PI3K/Akt and ERK signaling pathways on Nrf2 
induction 
 
After induction of Nrf2 antioxidant signaling in response to 27-OH was 
deciphered, the impact of survival signaling pathways including PI3K/Akt and ERK on 
Nrf2 induction was investigated. With this aim, to determine the dependence of the 
upregulation of Nrf2 protein level and nuclear translocation in U937 cells challenged 
with 10 µM 27-OH upon the phosphorylation of either ERK or Akt by this oxysterol 
was proved by a series of immunoblotting experiments employing pharmacological 
inhibitors of these kinases. Pretreatment of U937 cells with PD98059 (40 M), the 
MEK/ERK inhibitor or with LY294002 (25 μM), the PI3K/Akt inhibitor significantly 
prevented the 27-OH-mediated upregulation of Nrf2 protein level, as observed after 1 
and 3 h oxysterol treatment (Fig. 4.20 A). In addition, as shown in Fig. 4.20 B, the 
inhibition of ERK and Akt survival signaling with PD98059 or LY294002 respectively 
resulted a significant downregulation of the 27-OH-induced nuclear translocation of 
Nrf2 observed after 1 h treatment with the oxysterol. Based on these findings it can be 
suggested that ERK1/2 and PI3K/Akt are upstream regulators of Nrf2 pathway and 
modulate the nuclear localization of Nrf2 transcription factor in U937 promonocytic 
cells incubated in the presence of low micromolar amount of the oxysterol. 
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Figure 4.20. Inhibition of MEK/ERK and PI3K/Akt signaling pathways downregulates 
Nrf2 induction. U937 cells were either treated with 27-OH (10 μM) alone or pre-
incubated with PD98059 (40 μM) or LY294002 (25 μM) 45 min before 27-OH 
treatment. Untreated cells were taken as controls. (A) Nrf2 protein levels were analyzed 
by Western blotting. Αctin was used as loading control. (B) Nrf2 levels in nuclear and 
cytoplasmic lysates were determined by Western blotting. Lamin A/C and actin are used 
as loading controls. One blot representative of three experiments is shown. Histograms 
represent the mean values ± S.D. of all three independent experiments; **p < 0.01 and 
***p < 0.001 vs. control group; #p < 0.05, ##p < 0.01 and ###p < 0.001 vs. 27-OH. 
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4.14. Effect of 27-OH induced PI3K/Akt and ERK signaling pathways on HO-1 
and NQO-1 induction 
 
To examine the effect of 27-OH induced PI3K/Akt and ERK signaling pathways 
on HO-1 and NQO-1 induction, protein level of these detoxyfying enzymes were 
analyzed by Western blotting. For this purpose, U937 cell aliquots were preincubated 
(45 min) with either 40 M PD98059 or 25 μM LY294002 then challenged with low 
dose of oxysterol. Immunoblotting results showed that inhibition ERK signaling by 
PD98059 dramatically reduced HO-1 protein levels after 6 and 12 h treatment with 10 
M 27-OH (Fig 4.21 A). Moreover, cell pre-incubation with PI3K/Akt inhibitor, 
LY294002 fully prevented HO-1 expression after 6 and 12 h treatment of the oxysterol. 
Furthermore, the effect of these metabolic inhibitors was also examined for NQO-1 
protein after 24 and 48 h treatment with 27-OH (Fig 4.21 B). It has been clearly 
demonstrated that pretreatment with Erk and Akt inhibitors remarkably prevented 27-
OH-induced NQO-1 upregulation in U937 cells. This effect was observed more 
significantly after 24 h treatment of the oxysterol.  In the light of these results, it can be 
suggested that ERK and PI3K/Akt survival signaling pathways are involved in 27-OH-
induced upregulation of HO-1 and NQO-1 detoxyfying genes in U937 cells. 
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Figure 4.21. Effects of MEK/ERK or PI3K/Akt inhibition on HO-1 and NQO-1 
induction. U937 cells were either treated with 27-OH (10 μM) alone or pre-incubated 
with PD98059 (40 μM) or LY294002 (25 μM) 45 min before 27-OH treatment. 
Untreated cells were taken as controls. (A) Protein levels of HO-1 and (B) NQO-1 were 
analyzed by Western blotting. Αctin was used as loading control. One blot 
representative of three experiments is shown for each protein. Histograms represent the 
mean values ± S.D. of all three independent experiments; *p < 0.05, **p < 0.01 and 
***p < 0.001 vs. control group; #p < 0.05, ##p < 0.01 and ###p < 0.001 vs. 27-OH. 
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4.15. Effect of ROS up-regulation on 27-OH induced Nrf2 expression 
 
It has been clearly established that mitochondrial ROS play a critical role in 
activation of downstream antioxidant mechanisms, including Nrf2/ARE pathway 
(Cheng et al., 2011). We have showed above that ROS were generated through the 
derangement of mitochondrial membrane potential and activation of Nox-2 in response 
to low dose of 27-OH in human promonocytic cells. Based on these findings, we 
determined to investigate whether mitochondrial and Nox-2 sourced ROS could play a 
critical role in mediating 27-OH-induced Nrf2 up-regulation. Therefore, U937 cell 
suspensions were pretreated with or without the antioxidant NAC prior to 3 h incubation 
with 10 M 27-OH, and Nrf2 total cellular levels were analyzed by Western blotting 
(Fig. 4.22 A). Interestingly, it was observed that the 45 min cell pretreatment with 100 
M NAC significantly prevented 27-OH-dependent upregulation of Nrf2 cell protein 
level. Moreover, statistical analysis reported that as a result of quenching ROS by 
antioxidant NAC, Nrf2 protein content nearly halved in NAC + 27-OH treated cells in 
comparison to cells treated with the oxysterol alone (Fig. 4.22 A). Notably, cell 
pretreatment with NADPH oxidase inhibitor, DPI, gave a similar result. In particular, as 
shown in Fig. 4.22 B, pre-incubation of U937 cells with 50 M DPI significantly 
prevented the induction of Nrf2 after 3 h oxysterol treatment. These findings indicated 
that ROS upregulation has a modulatory role in 27-OH induced Nrf2 expression. 
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Figure 4.22.  Modulation of Nrf2 induction by N-acetyl cysteine (NAC) and 
diphenyleneiodonium chloride (DPI). (A) Effect of NAC (B) DPI on 27-OH-dependent 
Nrf2 induction. Cells were treated for 3 h with 27-OH at the final concentration of 10 
μM. Untreated cells were taken as controls. Other cells were pre-incubated (1 h) with 
(A) 100 μM NAC or (B) 50 μM DPI and then treated with 27-OH for 3 h. Protein level 
of Nrf2 was analyzed by Western blotting. Αctin was used as loading control. One blot 
representative of three experiments is shown. Histograms represent the mean values ± 
S.D. of all three independent experiments; *p < 0.05 and **p < 0.01 vs. control group; 
#p < 0.05 and ##p < 0.01 vs. 27-OH. 
 
4.16. Involvement of Nrf2 in 27-OH induced survival response in U937 
promonocytic cells 
 
Once demonstrated that 27-OH-induced phosphorylation of ERK and Akt 
pathways was in turn involving the activation of Nrf2, the possible role of the latter 
event in delaying the oxysterol’s pro-apoptotic effect was investigated. For this purpose, 
cells were transfected with specific Nrf2 siRNA and subjected to DAPI staining to 
analyze cell death. As shown in Fig. 4.23, molecular inhibition of Nrf2 caused a marked 
increase in the number of apoptotic cells already after 24 h incubation with 10 M 27-
OH, while the cell incubation with the oxysterol alone did not show any difference as to 
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untreated control cells. According to these results, the actual role of Nrf2 in low 
concentration of 27-OH induced survival response was validated. 
 
 
 
Figure 4.23. Evaluation of apoptosis by DAPI staining. U937 cells were transfected 
with a specific Nrf2 siRNA for 24 h and then incubated with 10 M 27-OH for 24 h. 
Apoptotic cells were evaluated in terms of DAPI staining and examined using a 
fluorescence microscope (Zeiss Axiovert 200 M) with an ultraviolet filter and a 
20x/0.30 lens. 
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5. DISCUSSION AND CONCLUSION 
 
 
 
5.1 Redox modulated 27-hydoroxycholesterol-induced survival signaling 
 
Oxidative modification of low-density lipoproteins (LDL) has been implicated to 
play a role in the pathogenesis of several oxidative-stress related chronic diseases that 
include atherosclerosis, preeclampsia, diabetes, and also in the acceleration and 
worsening of the aging process. Oxysterols are quantitatively relevant components of 
oxidized LDL (oxLDL) and their pro-inflammatory, pro-fibrogenic and pro-apoptotic 
effects were well-characterized in vascular cells. 27-hydroxycholesterol (27-OH) is one 
of the most represented oxysterols in the human circulation and also in atherosclerotic 
lesions (Khatib and Vaya, 2014). On behalf of its important role in pathophysiology, 
27-OH has been shown to induce LXR-dependent pathways and increase the risk of 
breast cancer by acting as a selective estrogen receptor modulator (Janowski et al., 
1999, 1996). In this relation, anti-apoptotic signals induced by 27-OH should be 
investigated in depth.  
 
 In the present thesis, it was demonstrated that survival signaling inducible by 
low concentrations of 27-OH involves the MEK/ERK and PI3K/Akt phosphorylation 
pathways in cells of monocyte lineage. Namely, enhanced MEK-ERK/PI3K-Akt 
phosphorylation followed by a net phosphorylation of pro-apoptotic Bad protein, 
respectively at Ser75 and at Ser99, results in macrophagic apoptotic death delay. 
Moreover, up-regulation of both kinases depends on oxysterol’s pro-oxidant effect 
which likely to be the key mechanism in this survival response.  
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Among the previously published studies focusing on the survival signaling 
induced by oxysterols, Berthier et al. reported that THP-1 monocytic cells treated with 
7K (100 µM) upregulated ERK 1/2 phosphorylation (between 1 and 6 h), consequent 
phosphorylation of Bad at residue Ser75 (Berthier et al., 2005). Unlike our data which is 
shown in Fig.4.5. , Akt phosphorylation at Thr 308 was downregulated in response to 
7K. It can be suggested that usage of different cell lines and the relatively greater 
cytotoxicity of 7K than 27-OH caused this discrepancy. Because of 27-OH is very good 
while 7K is very poor ligands of LXRs both oxysterols induce MEK/ERK-dependent 
survival signaling rules out involvement of LXRs in this kinase phosphorylation. A 
recent study using another oxysterol demonstrated that the human cholangiocyte 
MMNK-1 cells challenged with cholestan-3,5,6-triol (Triol) activated anti-apoptotic 
signaling via ERK phosphorylation (Jusakul et al., 2013). However, triol is considered 
as a poor LXR ligand while its concentration is negligible in human blood. 
 
In an interesting study, the same cell line with our study, U937 monocytes, after 
phorbol myristate acetate (PMA) differentiation, was treated with 28 µM final 
concentration of 27-OH, authors observed a significant induction of cell viability as 
well as enhancement of Akt phosphorylation at residue Thr308 (Riendeau and Garenc, 
2009). The oxysterol incubation time frame of that study was limited to 24 h, whereas 
we challenged monocytes with oxysterol till 72 h in most cases. On the other hand, 
neither modulation of Akt phosphorylation, nor pro-survival signaling, was detectable 
when the same 27-OH concentration was added to cultured human aortic smooth 
muscle cells suggesting that pro-survival response induced by oxysterol is cell specific. 
 
Accumulating evidence including our present findings showed that 27-OH 
modulate survival signaling through MEK/ERK and PI3K/Akt survival signaling 
pathways in cells of the macrophage lineage. As macrophages have been shown to 
induce CYP27A1 expression, the enzyme that catalyses  27-OH production, 
understanding this enzymatic process in detail became a trend topic among immunology 
studies (Westman et al., 1998). Moreover, our data indicate that 27-OH trigger the 
MEK/ERK - PI3K/Akt pro-survival axis which is a well known contributor to the 
carcinogenesis, thus targeting this intracellular axis is a promising therapy against 
cancer resistance. 
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 In Fig.4.4., the 27-OH amount actually present in promonocytic cells was 
quantified showing that only 20% amount of 10 M oxysterol was recovered 
throughout the experiment whereas the actual amount of oxysterols recovered was 
reported as above 1-2 x 10
-6
 M in atherosclerotic lesions (Carpenter et al., 1995). 
 
 Regarding the impact of ROS in this survival response, the pro-oxidant activity 
of 27-OH was confirmed with several experiments as shown in Fig. 4.11, 4.12. and 
4.13. In addition to this, pretreatment of cells with the antioxidant NAC decreased 
ERK1/2 and Akt phosphorylation clarified the mechanism underlying marked pERK 
and pAkt levels in which ROS has an active role in the enhanced kinase 
phosphorylation and in the related survival response (Fig. 4.14.). With regard to cellular 
sources of ROS, we demonstrated a Nox-2 dependent ROS increase as well as a 
derangement of the mitochondrial membrane potential of U937 cells. In parallel to our 
data, in macrophage colon-stimulating factors (M-CSF)-stimulated human 
monocytes/macrophages, upregulation of Nox-2 dependent ROS and the ROS-
dependent enhancement of pAkt have been demonstrated where knocking-out p47
phox 
and pretreatment
 
with NAC inhibited these two events (Wang et al., 2007). 
 
Besides demonstrating the survival effect of low concentrations of 27-OH, we 
also observed the high micromolar amount of the oxysterol. As depicted in Fig 4.6., 27-
OH did not stimulate the survival signaling regarding the Erk/Akt axis enhancement. On 
the other hand, 100 µM of 27-OH exerted a constant pro-oxidant effect and also 
stimulated apoptosis of human promonocytic cells at an earlier time period. 
 
 As we discussed above the ROS-dependent ERK and Akt phosphorylation in 
low concentrations of 27-OH-treated promonocytic cells was demonstrated. In addition 
to this, a very interesting data showed that upregulation of the ERK/Akt axis was able to 
quench ROS increase induced by 27-OH itself. As shown in 4.11., in cells treated with 
27-OH between 6 and 48 h incubations, ROS production was decreased coinciding with 
the time period of phosphorylation of ERK and Akt was upregulated. Furthermore, a 
biphasic pattern was observed for the oxidative stress provoked by 27-OH when up-
regulation of the ERK/Akt axis was downregulated by pretreatment of selective 
inhibitors (Fig 4.15.). According to these findings, it can be suggested that an induction 
of antioxidant defense system may modulate the quenching of ROS by enhancement of 
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ERK-Akt phosphorylation (Papaiahgari et al., 2006; Wang et al., 2012). Thus, we 
further investigate the role of Nrf2 and its antioxidant response in the quenching of ROS 
levels which modulated by the activated survival signaling. 
 
5.2 Involvement of Nrf2 antioxidant defense in 27-hydoroxycholesterol-induced 
survival signaling 
 
 
In the first part of this thesis, we demonstrated that low concentrations of 27-OH 
stimulated survival signaling in a ROS-dependent manner that upregulated MEK-
ERK/PI3K-Akt pathways with consequent quenching effect on ROS intracellular level 
(Vurusaner et al., 2014). To elucidate the complex mechanism that define the link 
between survival signaling pathways and down-regulation of ROS production, in the 
second part of the study, induction of Nrf2 antioxidant pathway was investigated.  
 
Based on the findings, it can be discussed that in U937 promonocytic cells, low 
micromolar concentration of 27-OH induced the activation of Nrf2 redox-sensitive 
transcription factor and its target genes including HO-1 and NQO-1 (Vurusaner et al., 
2016). Notably, activation of Nrf2-dependent antioxidant response by the oxysterol was 
demonstrated to dependent upon the up-regulation of MEK/ERK and PI3K/Akt 
signaling pathways. Moreover, it was observed that Nrf2 plays a key role in the 
quenching of intracellular oxidative stress and also in the 27-OH-induced survival 
signaling. 
 
In a very recent study, Kim et al. demonstrated the enhancement of ERK/Akt 
phosphorylation in response to 27-OH in THP-1 monocytic cells, however induction of 
Nrf2 by low micromolar concentrations of this oxysterol has not been previously shown 
(Kim et al., 2014). In another study, vascular cells lines treated with oxLDLs were 
shown to activate Nrf2, therefore suggesting that this redox-sensitive transcription 
factor involved in the signaling pathways such as CD36 regulation that sustain 
atherosclerosis progression (Ishii et al., 2004). In the same study, it was suggested that 
modulation of Nrf2 antioxidant response could depend onthe type of cell and the type of 
chemical inducer where oxLDLs induced Nrf2 activation more strongly in macrophages 
than in smooth muscle cells, but 4-hydroxynonenal (HNE) equally stimulated Nrf2 
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translocation in both cell lines. In contrast to our findings (Fig. 4.17. and 4.19), in C6 
glioma cells challenged with 10-20 M 27-OH, both expression and synthesis of Nrf2 
and its targets genes HO-1, NQO-1 and -GCS were downregulated in response to 
oxysterol (Ma et al., 2015). These few relevant reports together with our findings 
supported the cell specificity for the given response. 
As shown in Fig. 4.19, in promonocytic cells challenged with 10 M of 27-OH, 
protein levels of HO-1 and NQO-1 upregulated between 1 and 12 h of incubation that 
coinciding with phosphorylation of Erk and Akt time period. Interestingly, after 48 h 
oxysterol treatment HO-1 synthesis was started to decrease that consistent with ROS 
reappearance period at 72 and 96 h incubation times. On the other hand, the other 
cytoprotective enzyme, NQO-1 remained increased at 48 and 72 h of cell incubation. 
Thus, it can be suggested that HO-1 seems more involved than NQO-1 in quenching the 
pro-oxidant effect of 27-OH. It has been well reported that HO-1 and NQO-1 
antioxidant enzymes expressed in all main cell types present in human and mouse 
atherosclerotic lesions, such as smooth muscle cells, macrophages and  endothelial cells 
(Araujo et al., 2012). In parallel to our findings,  moderately oxidized LDL were shown 
to upregulate HO-1 expression in a Nrf2-dependent manner in vascular smooth muscle 
cells (Anwar et al., 2005). Another study reported that in endothelial cells challenged 
with the oxidized phospholipid oxPAPC, Nrf2-dependent HO-1 and NQO-1 induction 
was observed ( Jyrkkänen et al., 2008). 
 
In the “Introduction” section we mentioned the modulation of Nrf2 nuclear 
translocation by ERK1/2, p38 MAPK, PKC and PI3K/Akt signaling pathways. Based 
on the previous reports and our data, it can be suggested that the intensity of these 
upstream signaling pathways that modulate Nrf2 nuclear translocation varies with the 
different inducers in the different cell types. In this relation, in pulmonary epithelial 
cells ROS-dependent ERK and Akt activation was shown to induce translocation of 
Nrf2 to the nucleus (Papaiahgari et al., 2004). Similarly, in PC12 pheochromocytoma 
cells Nrf2 protein increased was observed in a PI3K/Akt-dependent manner (Martin et 
al., 2004). Similar to these results, we demonstrated ERK and Akt-dependent Nrf2 and 
its target genes, HO-1 and NQO-1 induction in response to low micromolar amounts of 
27-OH (Fig. 4.20 and 4.21.) where using selective inhibitors, both expression and 
synthesis of Nrf2 was inhibited. In consistent with these findings, the effect of Nrf2 in 
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modulation of survival signaling was evaluated by using Nrf2 siRNA and a Nrf2-
dependent survival response was observed in DAPI staining experiments (Fig. 4.23.). 
Another interesting data was that up-regulation of HO-1 and NQO-1 by 27-OH 
was prevented by pretreating cells with selective inhibitors of ERK and PI3K/Akt 
pathways (Fig. 4.21.).  Similar to our findings, Iles et al. reported that in epithelial cells 
HNE induced HO-1 via ERK signaling pathway (Iles et al., 2005). In agreement with 
this, in human vascular smooth muscle cells challenged with moderately oxidized LDL, 
HO-1 induction through activation of MAPK pathway was observed (Anwar et al., 
2005). While HO-1 upregulation by defined metabolites of the prostaglandin J(2) series 
was observed in HepG2 hepatoma cells, this induction was not inhibited by the ERK1/2 
inhibitor PD98059, suggesting that enhancement of this antioxidant enzyme might be 
modulated through more than a single upstream pathway (Liu et al., 2004). 
 
Finally, as shown in Fig. 4.22, in U937 cells pretreated with NAC or DPI, the 
induction of Nrf2 antioxidant signaling by low concentrations of 27-OH was prevented. 
In consistent with our findings, several studies demonstrated that inhibiting NADPH 
oxidase activity with DPI reduced nuclear transposition of Nrf2 in response to hypoxia 
in epithelial cells (Papaiahgari et al., 2006, 2004).  
 
5.3. Conclusions 
 
 According to data obtained, it appears that 27-OH triggers survival signals 
involving ERK/Akt axis, at least in monocytic cells and its pro-oxidant effect is the key 
mechanism in this survival response. The study also provides evidence for a “Trojan 
horse” action of this oxysterol (Biasi et al., 2004). Notably, when cells challenged with 
relatively low, and not directly toxic amounts of 27-OH that reflects a more realistic 
approach, the oxysterol’s pro-survival effect was observed.  Instead of killing the cell 
directly, 27-OH and also by related compounds might delay the irreversible damage 
they can cause, at the same time initiating pro-inflammatory and pro-fibrogenic 
pathways. Therefore, it can be suggested that delayed macrophage apoptosis would 
favor growth and consequent destabilization of advanced atherosclerotic plaques 
(Martinet et al., 2012). 
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In summary, as schematically shown in Fig. 5.1 (graphical abstract) the ROS-
mediated up-regulation of ERK/Akt phosphorylation, induced by low micromolar 
concentration of 27-OH is primary responsible for a significant induction Nrf2 and 
stimulated expression and synthesis of Nrf2 target enzymes, HO-1 and NQO-1. 
Moreover, molecular events modulate the pro-oxidant effect of 27-OH by a transient 
inhibition and, interestingly, able to prolonge the survival of cells challenged by the 
oxysterol. On the other hand, relatively high micromolar amount of 27-OH did not exert 
any survival effect in promonocytic cells, but a constant pro-oxidant effect was 
observed.  
 
Based on the literature, survival signaling elicited by 27-OH should appear 
beneficial and might involved in processes related to inflammation. On the other hand, 
oxysterol modulated cell survival could have detrimental effects like favoring the 
tumorigenesis in the case of chronic inflammation. Therefore, the potential beneficial or 
detrimental effect of these compounds appears to depend on different physiological 
processes and their grade of disease progression. It is worth to consider whether 
oxysterols are friends or foes. 
 
In conclusion, the findings obtained from this thesis highlight that cholesterol 
oxidation by-products involved in the pathogenesis of oxidative stress related chronic 
diseases like atherosclerosis and cancer.. Therefore, to understand deeply the complex 
mechanism and to generate synthetic or natural molecules targeting this survival 
mechanism might be a very promising tool in the prevention such diseases. 
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.  
Figure 5.1. Schematic flow sheet of 27-hydroxycholesterol-induced redox and Nrf2 
modulated survival signaling 
 
5.4. Future Studies 
 
The combined modulation of ERK/Akt phosphorylation and cellular redox state, 
as well as the induction of Nrf2 antioxidant response, here demonstrated for a low 
concentration of 27-OH, might be investigated also for other lipid oxidation products 
implicated in the pathogenesis of atherosclerosis and other inflammation-driven chronic 
92 
 
diseases. Furthermore, to understand whether a cell specificity is the fact that the 
survival mechanism evoked by 27-OH in U937 monocytic cells, our approach could be 
tested in other vascular cell lines such as endothelial and smooth muscle cells.  
 
In recent years, research on autophagy is a growing field with the aim of 
elucidation of its complex mechanism. It has become accepted that although autophagy 
has been regarded as cell survival mechanism, under certain conditions, excessive 
autophagy may leads to a caspase-independent, non-apoptotic type of cell death (Type 
II cell death) (Galluzzi et al., 2009). Despite the increasing interest in understanding the 
mechanism of autophagy, there is limited information on how cellular signaling 
pathways, regulate this complex process. It is now well established that autophagy is 
stimulated in advanced atherosclerotic plaques by inflammation and oxidized lipids 
where progression of atherosclerosis is characterized by formation of these plaques 
(Martinet and De Meyer, 2009). The protective role of autophagy in atherosclerosis 
involves the removal of damaged organelles by autophagy in response to mild oxidative 
stress which contributes to cellular recovery (Kiffin et al., 2006). Further studies are 
required to distinguish the relation between oxysterols and autophagy. Of note, relating 
this crosstalk to atherosclerosis progression and developing therapeutic interventions to 
target such diseases are exciting prospects for future studies. 
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APPENDIX 
 
 
 
 
APPENDIX A 
 
 
 
Chemicals (in alphabetical order) 
Name of Chemical Supplier Company 
  2-Mercaptoethanol Fluka, Switzerland 
27-Hydroxycholesterol Steraloids Inc., USA 
27-OH-d7 Avanti PolarLipids, USA 
4-Hydroxyphenylacetic acid Sigma, Germany 
Acetic Acid Merck, Germany 
Acrylamide/Bis-acrylamide Sigma, Germany 
Acrylamide/Bis-acrylamide Biorad, USA 
Ammonium Persulfate Sigma, Germany 
Bradford solution Biorad, USA 
BSA Promega, USA 
BSA Amresco, USA 
Bromophenol Blue Sigma, Germany 
Coomassie Brilliant Blue Merck, Germany 
DAPI Roche, Germany 
DC protein assay Biorad, Germany 
Developer/Replenisher Agfa, Belgium 
DHE Sigma, Germany 
Distilled water Milipore, France 
DMSO Sigma, Germany 
DPI Sigma, USA 
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DTT Sigma, Germany 
EDTA Riedel-de Haen, Germany 
EGTA Riedel-de Haen, Germany 
Ethanol Riedel-de Haen, Germany 
Ferrocytochrome c Sigma, Germany 
Fixer E.O.S. Agfa, Belgium 
Foetal Bovine Serum (FBS) Pan, Fermany 
Glycerol Riedel-de Haen, Germany 
Glycine Molekula, UK 
HCl Merck, Germany 
HEPES Molekula, UK 
Hyperfilm ECL Amersham, UK 
Isopropanol Riedel-de Haen, Germany 
JC-1 Life Technologies, Italy 
KCl Amresco, USA 
KH2PO4 Riedel-de Haen, Germany 
KOH Riedel-de Haen, Germany 
L-Glutamine Sigma, Germany 
Liquid nitrogen Karbogaz, Turkey 
LY294002  Calbiochem, USA 
Methanol Riedel-de Haen, Germany 
MgCl2 Sigma, Germany 
Milk Diluent concentrate KPL, USA 
Na2HPO4 Merck, Germany 
NAC Sigma, Germany 
NaCl Riedel-de Haen, Germany 
NP-40 Sigma, Germany 
PD98059 Calbiochem, USA 
Penicillin-Streptomycin PAN, Germany 
Phenol Amersco, USA 
phoSTOP phosphatase inhibitor Roche, Switzerland 
PMSF Sigma, Germany 
Protease inhibitor coctail tablet Roche, Switzerland 
PVDF membrane Amersham, UK 
RPMI 1640 PAN, Germany 
Sodium Dodecyl Sulphate  Sigma, Germany 
TEMED Sigma, Germany 
Tris  Molekula, UK 
Tween20 Molekula, UK 
X-ray Film Biomax MS-1 Sigma, Germany 
X-ray film  Sigma, Germany 
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APPENDIX B 
 
 
 
Antibodies and enzymes (in alphabetical order) 
 
Name  Supplier Company 
  Anti--Actin Cell Signaling, USA 
Anti-Akt Cell Signaling, USA 
Anti-p-Akt Cell Signaling, USA 
Anti-p-Bad Cell Signaling, USA 
Anti-Bcl-xl Cell Signaling, USA 
Anti-Bim Cell Signaling, USA 
Anti-cleaved caspase 3 Cell Signaling, USA 
Anti- ERK1/2 Cell Signaling, USA 
Anti-p-ERK1/2 Cell Signaling, USA 
Anti-HO-1 Cell Signaling, USA 
Anti-Lamin A/C Cell Signaling, USA 
Anti-mouse HRP Cell Signaling, USA 
Anti-Nrf2 Cell Signaling, USA 
Anti-NQO-1 Cell Signaling, USA 
Anti-rabbit HRP Cell Signaling, USA 
Anti-rabbit FITC Abcam, UK 
RNase -Superase In Life technologies, USA 
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APPENDIX C 
 
 
 
Molecular biology kits and reagents (in alphabetical order) 
  Name Supplier Company 
  AnnexinV-FITC  Alexis, USA 
ECL Advance Amersham, UK 
Hs_NFE2L2 s9493 siRNA Applied Biosystems, USA 
High-Capacity cDNA synthesis Kit Life Technologies, USA 
Negative Control siRNA  Applied Biosystems, USA 
NeoFX transfection reagent Applied Biosystems, USA 
Quantitech RT Kit Qiagen, Netherlands 
Quantitech SYBRgreen KĠT Qiagen, Netherlands 
Taq PCR Master Mix Kit Qiagen, Netherlands 
Trizol Life Technologies, USA 
WST-1 (Cell Proliferation Kit ) Roche, Germany 
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APPENDIX D 
 
 
 
Buffers and solutions (in alphabetical order) 
Standard buffers and solutions used in this study were prepared according to the 
protocols in Molecular Cloning: A Laboratory Manual, Sambrook et al., 2001. 
(Sambrook and MacCallum, 2013). 
 
Annexin-V staining buffer 
100 l cell suspension in FACS incubation buffer 
2 l Annexin-V (Alexis) 
 
 
Blocking solution 
5 g nonfat dried milk 
100 ml washing solution 
 
 
Complete lysis buffer 
20 mM Tris-HCl (pH 7.5) 
150 mM NaCl 
NP-40 0.5% (v/v) 
1 mM EDTA 
0.5 mM PMSF 
1 mM DTT 
Protease and phosphatase inhibitor mix 
 
 
Cytosolic protein extraction buffer 
20 mM Hepes pH 7.9 
0.35 M NaCl 
 20% glycerol 
1% Igepal CA-630 
1 mM MgCl2 
0.5 mM EDTA  
0.1 mM EGTA 
Protease inhibitors 
 
 
DAPI stock solution (1000X) 
10 mg DAPI 
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10 ml ddH2O 
Store at -20°C 
 
DAPI working solution (1X) 
1 μl DAPI stock solution (1000X) 
1 ml Methanol (Store at +4°C up to 6 months) 
 
 
FACS incubation buffer 
10 mM HEPES 
140 mM NaCl 
2,5 mM CaCl2 
pH: 7,4 
 
 
Immunoblotting washing solution 
100 ml PBS (10X) 
900 ml ddH2O 
2 ml Tween20 (final: 0,2%) 
 
 
Phosphate-buffered saline (PBS) (10X) 
80 g NaCl 
2.25 g KCl 
23.27 g Na2HPO4 
2.05 g KH2PO4 
pH: 7,4 
Adjust to 1000ml with ddH2O 
 
 
PBS-Tween20 (PBST) solution (1X) 
0.5 ml Tween20  
Adjust to 1000 ml with 1X PBS 
 
 
Primary antibody incubation solution 
2 ml 5% (w/v) milk blocking solution  
1μg primary antibody 
 
 
Running buffer (10X) 
144.1g glycine 
30.3g Tris 
10g SDS 
Adjust to 1000ml with ddH2O 
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SDS Seperation Gel 
3.75 ml Tris/SDS (1.5M pH 8.8)  
5.25 ml H2O 
6 ml Acryl: Bisacryl (30%)  
50 μl 10% APS  
10 μl TEMED  
 
 
SDS Stacking Gel 
1.25 ml Tris/SDS (0.5M pH 6.8) 
3.05 ml H2O 
0.65 ml Acryl: Bisacryl (30%)  
25 μl 10% APS  
10 μl TEMED  
 
 
Secondary antibody incubation solution 
5 ml 5% (w/v) milk blocking solution 
1 μg secondary antibody 
 
 
T1 Buffer 
10 mM HEPES-KOH (pH: 7,9) 
2 mM MgCl2.6H2O 
0,1 mM EDTA 
10 mM KCl 
1% NP-40 
1 mM DTT (freshly added) 
0,5 mM PMSF (freshly added) 
Complete protease inhibitors (freshly added) 
 
 
T2 Buffer 
50 mM HEPES-KOH (pH: 7,9) 
2 mM MgCl2.6H2O 
0,1 mM EDTA 
50 mM KCl 
400mM NaCl 
10% (v/v) Glycerol 
1 mM DTT (freshly added) 
0,5 mM PMSF (freshly added) 
Complete protease inhibitors (freshly added) 
 
 
Transfer buffer (stock: 10X) 
144 g glycine 
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30.3 g Tris 
Adjust to 1000ml with ddH2O 
 
 
Transfer buffer (working: 1X) 
100 ml Transfer buffer (10X) 
700 ml ddH2O 
200 ml Methanol 
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APPENDIX E 
 
 
 
Protein Molecular Weight Marker 
 
 
 
Figure E.1: Protein Molecular Weight Marker (Fermentas, Germany) 
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APPENDIX F 
 
 
 
Equipments (in alphabetical order) 
Name Supplier Company 
  Autoclave Hirayama,Hiclave HV-110,Japan 
Balance Sartorius, BP221S, Germany 
 
Schimadzu, Libror EB-3200 HU, Japan 
Cell Counter Cole Parmer, USA 
Centrifuge Eppendorf, 5415D, Germany 
 
Eppendorf, 5415D, Germany 
Eppendorf, 5415R, Germany 
CO2 Incubator Binder,Germany 
Computer Software FlowJo V10 
 
Image J 1.42q 
Photoshop CS5 
Irfanview 4.20 
 
LSM 510 Image Examiner 
 
MS Office 2007 
Deepfreeze -80
o
C, Kendro Lab Prod., Heraeus Hfu486 Basic, 
 
Germany 
-20
o
C,Bosch,Turkey 
Distilled Water Millipore, Elix-S, France 
Flow Cytometer BD FACS Canto,USA 
Gel Documentation Biorad, UV-Transilluminator 2000, USA 
Heater Thermomixer Comfort, Eppendorf, Germany 
Hematocytometer Hausser Scientific,Blue Bell Pa.,USA 
Ice Machine Scotsman Inc., AF20, USA 
Incubator Memmert, Modell 300, Germany 
 
Memmert, Modell 600, Germany 
Laminar Flow Kendro Lab. Prod., Heraeus, HeraSafe HS12, Germany 
Liquid Nitrogen Tank Taylor-Wharton,3000RS,USA 
Magnetic Stirrer VELP Scientifica, ARE Heating Magnetic Stirrer, Italy 
Mass Spectrometer HP 5970 MSD, Agilent, USA 
Microliter Pipettes Gilson, Pipetman, France 
 
Eppendorf, Germany 
Mettler Toledo Volumate, USA 
Microscope Zeiss Axiovert 200 M, Milan Italy 
 
Zeiss LSM 510; Carl Zeiss S.p.A., Arese, Milan, Italy 
Microtiter plate reader Biorad, USA 
pH meter WTW, pH540 GLP MultiCal, Germany 
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Power Supply Biorad, PowerPac 300, USA 
 
Wealtec, Elite 300, USA 
Refrigerator Bosch,Turkey 
Spectrophotometer ND-1000, Nanodrop, USA 
 
Schimadzu UV-1208, Japan 
Scimadzu UV-3510, Japan 
  Thermocycler Eppendorf, Mastercycler Gradient, Germany 
Vortex Velp Scientifica,Italy 
Water bath                       Huber, Polystat cc1, Germany 
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